https://novapharmanews.com/us/news/sunlight-glp-1-2026-fda-decision-compounded-semaglutide 2026-06-03T18:19:13.868Z weekly 0.7 https://novapharmanews.com/us/news/us-fda-proposes-regulations-weight-loss-drug-compounding 2026-06-03T18:08:36.083Z weekly 0.7 https://novapharmanews.com/us/news/fda-peptides-bulk-drug-compounding 2026-06-03T16:08:42.718Z weekly 0.7 https://novapharmanews.com/us/news/fda-flashback-breast-cancer-april-2026 2026-06-03T16:02:34.906Z weekly 0.7 https://novapharmanews.com/us/news/fda-eases-restrictions-peptides-drug-approvals 2026-06-03T15:49:49.403Z weekly 0.7 https://novapharmanews.com/us/news/top-10-takeover-targets-2026 2026-06-03T15:43:41.685Z weekly 0.7 https://novapharmanews.com/us/news/eli-lilly-acquires-centessa-pharmaceuticals-market-analysis 2026-06-03T15:43:25.747Z weekly 0.7 https://novapharmanews.com/us/news/fda-easing-restrictions-unproven-peptides 2026-06-03T15:33:36.367Z weekly 0.7 https://novapharmanews.com/us/news/fda-approvals-oncology-jan-mar-2026 2026-06-03T15:30:23.551Z weekly 0.7 https://novapharmanews.com/us/news/fda-permanent-ban-compounded-glp-1s 2026-06-03T12:06:34.443Z weekly 0.7 https://novapharmanews.com/us/news/top-biotech-gainers-codx-nrxp-nvax-clinical-trials-update 2026-06-03T11:52:40.293Z weekly 0.7 https://novapharmanews.com/us/news/2025-drug-approvals-biopharma-resilience 2026-06-03T11:52:40.225Z weekly 0.7 https://novapharmanews.com/us/news/bayer-acquisition-eye-drug-biotech 2026-06-03T11:52:40.062Z weekly 0.7 https://novapharmanews.com/eu/news/us-europe-biosimilar-approvals-2026 2026-06-03T17:29:58.758Z weekly 0.7 https://novapharmanews.com/eu/news/2026-italy-drug-medical-device-litigation-report 2026-06-03T17:29:56.040Z weekly 0.7 https://novapharmanews.com/eu/news/who-europe-access-novel-medicines 2026-06-03T17:29:54.804Z weekly 0.7 https://novapharmanews.com/eu/news/fda-delays-astrazeneca-breast-cancer-drug-review 2026-06-03T16:26:53.063Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidance-next-gen-sequencing-gene-therapy-safety 2026-06-03T16:08:39.460Z weekly 0.7 https://novapharmanews.com/apac/news/akeso-lung-cancer-drug-outperforms-immunotherapy 2026-06-03T16:02:35.698Z weekly 0.7 https://novapharmanews.com/us/news/healthcare-dealmaker-megamergers-2026 2026-06-03T15:43:30.496Z weekly 0.7 https://novapharmanews.com/eu/news/rethinking-qa-qc-future-bio-pharmaceutical-analysis-2026 2026-06-03T15:42:04.413Z weekly 0.7 https://novapharmanews.com/eu/news/international-school-clinical-oncology-annual-congress-2026 2026-06-03T15:42:01.321Z weekly 0.7 https://novapharmanews.com/eu/news/bio-pharma-outlook-2026-regulatory-updates 2026-06-03T15:41:55.310Z weekly 0.7 https://novapharmanews.com/eu/news/ascentage-pharma-eha-2026-clinical-advances 2026-06-03T15:41:52.236Z weekly 0.7 https://novapharmanews.com/apac/news/pharmaceuticals-market-size-share-analysis-2034 2026-06-03T15:30:24.226Z weekly 0.7 https://novapharmanews.com/apac/news/decade-ai-medical-device-regulation-2015-2025 2026-06-03T15:30:20.672Z weekly 0.7 https://novapharmanews.com/apac/news/early-access-disparities-innovative-therapies 2026-06-03T12:32:13.110Z weekly 0.7 https://novapharmanews.com/us/news/pharma-in-focus-regulatory-updates 2026-06-03T11:52:32.829Z weekly 0.7 https://novapharmanews.com/us/news/fsma-final-rule-traceability-requirements 2026-06-03T11:52:27.802Z weekly 0.7 https://novapharmanews.com/us/news/chinese-pharma-innovators-global-expansion 2026-06-03T18:17:32.369Z weekly 0.7 https://novapharmanews.com/us/news/longeveron-q1-2026-financial-results-business-update 2026-06-03T17:44:59.722Z weekly 0.7 https://novapharmanews.com/us/news/altrx-glp-1-review-2026-fda-updates-semaglutide 2026-06-03T17:44:05.026Z weekly 0.7 https://novapharmanews.com/us/news/vir-astellas-240m-prostate-cancer-trials 2026-06-03T17:40:26.217Z weekly 0.7 https://novapharmanews.com/us/news/pennsylvania-compounding-pharmacy-fda-warning-letter 2026-06-03T14:51:25.508Z weekly 0.7 https://novapharmanews.com/us/news/global-ma-trends-health-industries-2026-outlook 2026-06-03T14:32:25.307Z weekly 0.7 https://novapharmanews.com/us/news/china-approves-hernexeos-lung-cancer-treatment 2026-06-03T14:24:08.097Z weekly 0.7 https://novapharmanews.com/us/news/jpm26-biotech-ma-insights-market-analysis 2026-06-03T14:17:27.612Z weekly 0.7 https://novapharmanews.com/us/news/wockhardt-us-fda-approval-zaynich 2026-06-03T13:32:21.337Z weekly 0.7 https://novapharmanews.com/us/news/resilience-reinvention-biotech-maturity 2026-06-03T13:14:23.470Z weekly 0.7 https://novapharmanews.com/us/news/fda-decisions-q2-2026-drug-approvals 2026-06-03T12:40:23.553Z weekly 0.7 https://novapharmanews.com/us/news/lilly-38b-investment-infectious-disease-portfolio 2026-06-03T17:53:00.397Z weekly 0.7 https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-clinical-data-eas-congress 2026-06-03T17:40:27.981Z weekly 0.7 https://novapharmanews.com/us/news/fda-device-guidance-agenda-2026 2026-06-03T17:33:24.037Z weekly 0.7 https://novapharmanews.com/eu/news/owkin-astrazeneca-ai-collaboration-drug-research 2026-06-03T15:41:47.421Z weekly 0.7 https://novapharmanews.com/eu/news/innovent-pfizer-cancer-drug-deal 2026-06-03T15:41:33.805Z weekly 0.7 https://novapharmanews.com/eu/news/cancer-therapy-ost-her2-2026-ema-call 2026-06-03T15:41:19.277Z weekly 0.7 https://novapharmanews.com/apac/news/asia-pacific-eclinical-solutions-market-report-2025-2030 2026-06-03T15:30:22.265Z weekly 0.7 https://novapharmanews.com/eu/news/innovent-biologics-shares-surge-pfizer-deal 2026-06-03T14:41:41.757Z weekly 0.7 https://novapharmanews.com/us/news/fda-new-guidance-ai-regulatory-restraint 2026-06-03T14:01:26.045Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-negative-stance-acadia-rett-syndrome-drug 2026-06-03T11:52:38.565Z weekly 0.7 https://novapharmanews.com/eu/news/lenz-therapeutics-vizz-ema-presbyopia 2026-06-03T11:52:38.555Z weekly 0.7 https://novapharmanews.com/apac/news/innovative-oncology-pharma-china 2026-06-03T11:52:36.542Z weekly 0.7 https://novapharmanews.com/apac/news/smarter-medical-devices-ecosystem-india-regulatory-updates 2026-06-03T11:52:36.409Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-asia-nadia-harbeck-oncology-advances 2026-06-03T11:52:28.927Z weekly 0.7 https://novapharmanews.com/apac/news/uk-clinical-trials-oncology-impact 2026-06-03T11:52:25.010Z weekly 0.7 https://novapharmanews.com/apac/news/biomarkers-digital-technologies-oncology-asia-2026 2026-06-03T11:52:10.766Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-may-2026-output-shift-european-drug-development 2026-06-03T17:25:57.327Z weekly 0.7 https://novapharmanews.com/us/news/lunai-bioworks-brainstorm-therapeutics-ai-collaboration 2026-06-03T08:28:31.835Z weekly 0.7 https://novapharmanews.com/us/news/big-pharma-ma-spree-march-ipo-drought 2026-06-03T18:05:31.857Z weekly 0.7 https://novapharmanews.com/us/news/bizengri-fda-national-priority-rare-bile-duct-cancer 2026-06-03T17:32:46.270Z weekly 0.7 https://novapharmanews.com/us/news/big-pharma-biotech-assets-patent-cliff 2026-06-03T14:36:09.641Z weekly 0.7 https://novapharmanews.com/us/news/pharmtech-regulatory-roundup-may-2026-drug-approvals 2026-06-03T14:24:16.809Z weekly 0.7 https://novapharmanews.com/us/news/ai-brain-organoids-parkinsons-rare-epilepsy-regulatory-updates 2026-06-03T13:21:27.387Z weekly 0.7 https://novapharmanews.com/us/news/ai-breast-cancer-risk-prediction-tool-fda-approval 2026-06-03T12:38:27.311Z weekly 0.7 https://novapharmanews.com/us/news/regeneron-fda-approval-neurosensory-gene-therapy 2026-06-03T12:26:12.571Z weekly 0.7 https://novapharmanews.com/us/news/pfizer-innovent-deal-global-drug-development-oncology 2026-06-03T11:52:41.257Z weekly 0.7 https://novapharmanews.com/us/news/regulatory-actions-may-2026 2026-06-03T11:52:34.531Z weekly 0.7 https://novapharmanews.com/us/news/fda-commissioner-resignation-drug-approvals 2026-06-03T09:41:34.646Z weekly 0.7 https://novapharmanews.com/us/news/pharma-ma-boom-2026-market-analysis 2026-06-03T06:01:46.494Z weekly 0.7 https://novapharmanews.com/us/news/states-confront-medical-chatbots-oversight-fda-inaction 2026-06-03T04:52:49.875Z weekly 0.7 https://novapharmanews.com/us/news/life-sciences-dealmaking-momentum-strategic-pressures 2026-06-03T04:52:47.959Z weekly 0.7 https://novapharmanews.com/apac/news/premia-lind-ai-clinical-trial-screening-asia-pacific 2026-06-03T17:40:31.184Z weekly 0.7 https://novapharmanews.com/eu/news/imfinzi-approval-bladder-cancer 2026-06-03T17:29:57.201Z weekly 0.7 https://novapharmanews.com/eu/news/imfinzi-fda-approval-bladder-cancer 2026-06-03T15:35:20.266Z weekly 0.7 https://novapharmanews.com/apac/news/clinical-trials-market-oncology-2034 2026-06-03T15:30:24.029Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-2025-preview-astra-daiichi-gilead 2026-06-03T15:15:08.920Z weekly 0.7 https://novapharmanews.com/eu/news/2026-cell-therapy-regulatory-landscape 2026-06-03T14:59:28.315Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-april-20-2026 2026-06-03T14:46:43.622Z weekly 0.7 https://novapharmanews.com/apac/news/onconic-therapeutics-jakubo-phase-3-clinical-trials-china 2026-06-03T14:30:10.306Z weekly 0.7 https://novapharmanews.com/apac/news/innovent-biologics-pfizer-10-5b-oncology-partnership 2026-06-03T13:52:02.031Z weekly 0.7 https://novapharmanews.com/eu/news/merz-therapeutics-kvvit-inbrija-agreement 2026-06-03T13:02:01.511Z weekly 0.7 https://novapharmanews.com/eu/news/prac-meeting-highlights-may-2026 2026-06-03T11:52:40.990Z weekly 0.7 https://novapharmanews.com/eu/news/critical-medicines-act-council-parliament-deal 2026-06-03T11:52:38.568Z weekly 0.7 https://novapharmanews.com/apac/news/cell-gene-therapy-approvals-china-regulatory-updates 2026-06-03T11:52:36.421Z weekly 0.7 https://novapharmanews.com/eu/news/pfizer-innovent-10-5bn-oncology-deal 2026-06-03T11:52:28.987Z weekly 0.7 https://novapharmanews.com/apac/news/sun-pharma-organon-acquisition-market-analysis 2026-06-03T16:21:49.941Z weekly 0.7 https://novapharmanews.com/us/news/longeveron-fda-meeting-elpis-ii-data 2026-06-03T11:52:41.338Z weekly 0.7 https://novapharmanews.com/us/news/seven-biopharma-trends-2026-clinical-trials 2026-06-03T11:52:40.535Z weekly 0.7 https://novapharmanews.com/us/news/leap-therapeutics-stock-edges-higher 2026-06-03T11:52:40.534Z weekly 0.7 https://novapharmanews.com/apac/news/middle-east-pharma-markets-api-china-2026 2026-06-03T11:52:36.561Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-durvalumab-bcg-high-risk-nmibc 2026-06-03T11:52:14.414Z weekly 0.7 https://novapharmanews.com/apac/news/global-drug-discovery-market-2035 2026-06-03T11:52:05.981Z weekly 0.7 https://novapharmanews.com/us/news/experimental-igg4-rd-drug-fda-submission 2026-06-03T04:53:57.948Z weekly 0.7 https://novapharmanews.com/eu/news/critical-medicines-act-europe-medicines-shortages 2026-06-03T17:36:56.906Z weekly 0.7 https://novapharmanews.com/eu/news/hansa-licenses-idefirix-serb-133m 2026-06-03T17:32:22.885Z weekly 0.7 https://novapharmanews.com/eu/news/camizestrant-eu-approval-advanced-er-positive-breast-cancer 2026-06-03T17:10:27.857Z weekly 0.7 https://novapharmanews.com/eu/news/ema-management-board-march-2026-clinical-trials 2026-06-03T16:00:56.205Z weekly 0.7 https://novapharmanews.com/apac/news/apac-clinical-trial-growth-oncology 2026-06-03T15:18:33.750Z weekly 0.7 https://novapharmanews.com/us/news/us-fda-decision-date-camizestrant-extended 2026-06-03T14:33:58.109Z weekly 0.7 https://novapharmanews.com/apac/news/exosome-based-therapeutics-market-2033-report 2026-06-03T13:06:32.800Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-strategy-reimagined-trends-accelerating-drug-development 2026-06-03T11:52:35.620Z weekly 0.7 https://novapharmanews.com/eu/news/imfinzi-approved-bladder-cancer-combo 2026-06-03T11:52:34.493Z weekly 0.7 https://novapharmanews.com/eu/news/tarsier-pharma-ipo-nyse-listings-expand 2026-06-03T11:52:29.212Z weekly 0.7 https://novapharmanews.com/apac/news/ai-tools-clinical-trials-life-sciences 2026-06-03T11:52:24.859Z weekly 0.7 https://novapharmanews.com/us/news/global-firms-china-deals-economic-uncertainty 2026-06-03T04:54:31.988Z weekly 0.7 https://novapharmanews.com/us/news/fda-loosens-regulations-digital-health-tools 2026-06-03T04:54:21.982Z weekly 0.7 https://novapharmanews.com/us/news/gsk-alfasigma-licensing-agreement-servier-acquisition 2026-06-03T04:54:07.977Z weekly 0.7 https://novapharmanews.com/us/news/biopharma-dealmaking-2025-market-analysis 2026-06-03T04:54:03.955Z weekly 0.7 https://novapharmanews.com/eu/news/european-critical-medicines-act-market-analysis 2026-06-03T18:13:02.235Z weekly 0.7 https://novapharmanews.com/apac/news/hanmi-pharma-organon-partnership-southeast-asia 2026-06-03T15:34:51.013Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-18-may-2026 2026-06-03T11:52:35.847Z weekly 0.7 https://novapharmanews.com/us/news/eli-lilly-acquires-vaccine-developers-38b 2026-06-03T07:10:09.532Z weekly 0.7 https://novapharmanews.com/eu/news/ai-accelerates-novo-nordisk-parkinsons-cell-therapy 2026-06-03T04:54:45.993Z weekly 0.7 https://novapharmanews.com/us/news/fda-restricts-compounding-weight-loss-drugs 2026-06-03T16:31:11.546Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidelines-generic-bioequivalence-oncology 2026-06-03T16:02:32.966Z weekly 0.7 https://novapharmanews.com/us/news/lifesaving-upgrades-fda-oncology-approvals 2026-06-03T15:30:27.790Z weekly 0.7 https://novapharmanews.com/apac/news/india-vietnam-relations-diplomatic-push 2026-06-03T14:35:13.810Z weekly 0.7 https://novapharmanews.com/apac/news/leaders-shape-future-healthcare-asgh-2026 2026-06-03T13:50:26.435Z weekly 0.7 https://novapharmanews.com/us/news/3-overlooked-stocks-soar-2026-clinical-trials 2026-06-03T11:52:40.602Z weekly 0.7 https://novapharmanews.com/us/news/top-10-anticipated-drug-launches-2026 2026-06-03T11:52:38.159Z weekly 0.7 https://novapharmanews.com/apac/news/immunotherapy-pet-ct-imaging-demand-australia 2026-06-03T11:52:22.473Z weekly 0.7 https://novapharmanews.com/apac/news/brenus-pharma-stc-1010-fda-acceptance 2026-06-03T11:52:22.456Z weekly 0.7 https://novapharmanews.com/us/news/astrazeneca-daiichi-drug-approval-breast-cancer 2026-06-03T04:54:54.020Z weekly 0.7 https://novapharmanews.com/us/news/sgs-acquires-keystone-bioanalytical-drug-development 2026-06-03T18:04:49.198Z weekly 0.7 https://novapharmanews.com/apac/news/nuance-pharma-ind-clearance-actair-china 2026-06-03T17:58:25.180Z weekly 0.7 https://novapharmanews.com/eu/news/ema-fda-good-ai-practice-drug-development 2026-06-03T17:43:04.938Z weekly 0.7 https://novapharmanews.com/eu/news/serd-therapy-anti-proliferative-activity-er-her2-breast-cancer 2026-06-03T16:39:08.317Z weekly 0.7 https://novapharmanews.com/eu/news/may-2026-global-health-wash-funding-opportunities 2026-06-03T16:26:50.600Z weekly 0.7 https://novapharmanews.com/us/news/chinas-licensing-boom-global-pipelines 2026-06-03T14:24:05.122Z weekly 0.7 https://novapharmanews.com/eu/news/key-cancer-drugs-esmo-2025 2026-06-03T12:46:37.765Z weekly 0.7 https://novapharmanews.com/us/news/industry-groups-fda-guidance-form-483 2026-06-03T11:55:44.400Z weekly 0.7 https://novapharmanews.com/eu/news/hayes-esmo-breast-cancer-award-2026 2026-06-03T11:52:38.735Z weekly 0.7 https://novapharmanews.com/apac/news/blockbuster-drugs-patent-cliff-2026-oncology 2026-06-03T11:52:36.528Z weekly 0.7 https://novapharmanews.com/eu/news/eu-draft-deal-essential-medicine-shortages 2026-06-03T11:52:32.337Z weekly 0.7 https://novapharmanews.com/eu/news/fda-real-time-clinical-trials-progress 2026-06-03T11:52:29.239Z weekly 0.7 https://novapharmanews.com/us/news/fda-clarifies-3-year-exclusivity-guidance 2026-06-03T10:26:51.436Z weekly 0.7 https://novapharmanews.com/eu/news/europe-boost-clinical-trials 2026-06-03T08:38:34.920Z weekly 0.7 https://novapharmanews.com/eu/news/us-eu-pharmaceutical-regulations-concerns 2026-06-03T04:55:48.149Z weekly 0.7 https://novapharmanews.com/us/news/astellas-xtandi-patent-cliff-strategic-moves 2026-06-03T15:22:41.617Z weekly 0.7 https://novapharmanews.com/eu/news/critical-medicines-act-impact-pharmaceutical-manufacturing-europe 2026-06-03T15:22:09.879Z weekly 0.7 https://novapharmanews.com/eu/news/maat-pharma-q1-2026-business-update 2026-06-03T14:28:37.773Z weekly 0.7 https://novapharmanews.com/us/news/best-biotech-stocks-may-2026-clinical-trials 2026-06-03T13:28:53.099Z weekly 0.7 https://novapharmanews.com/apac/news/60-degrees-pharmaceuticals-tafenoquine-clinical-trial-babesiosis 2026-06-03T11:52:38.554Z weekly 0.7 https://novapharmanews.com/apac/news/bukwang-pharmaceutical-dreamcis-aws-clinical-trials 2026-06-03T11:52:24.870Z weekly 0.7 https://novapharmanews.com/us/news/fda-vs-ema-camizestrant-controversy 2026-06-03T11:52:14.426Z weekly 0.7 https://novapharmanews.com/apac/news/lundbeck-korean-approval-vyepti-oncology-migraine 2026-06-03T04:55:56.154Z weekly 0.7 https://novapharmanews.com/us/news/fda-new-form-483-response-guidance 2026-06-03T18:06:15.912Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-breast-cancer-congress-2026-highlights 2026-06-03T04:56:10.182Z weekly 0.7 https://novapharmanews.com/us/news/fda-drug-approval-decisions-may-2026 2026-06-03T11:52:38.642Z weekly 0.7 https://novapharmanews.com/apac/news/clinical-trials-day-2026-oncology-study-growth 2026-06-03T11:52:24.890Z weekly 0.7 https://novapharmanews.com/us/news/liminatus-pharma-innocsai-merger-market-analysis 2026-06-03T05:45:19.893Z weekly 0.7 https://novapharmanews.com/apac/news/health-news-round-up-immunotherapy-pcos-clopidogrel-trials 2026-06-03T04:56:26.290Z weekly 0.7 https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-competitive-headwinds 2026-06-03T04:56:24.571Z weekly 0.7 https://novapharmanews.com/us/news/aurobindo-pharma-oai-classification-drug-approvals 2026-06-03T04:56:16.183Z weekly 0.7 https://novapharmanews.com/eu/news/ireland-clinical-trials-eu-comparison 2026-06-03T04:56:12.175Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-meeting-highlights-drug-approvals-april-2026 2026-06-03T07:37:07.275Z weekly 0.7 https://novapharmanews.com/eu/news/european-biotechs-cell-gene-therapy-manufacturing 2026-06-03T15:30:21.392Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-17-drugs-continuous-manufacturing 2026-06-03T15:26:33.993Z weekly 0.7 https://novapharmanews.com/us/news/rfk-jr-drug-approval-speed-oncology 2026-06-03T11:56:08.066Z weekly 0.7 https://novapharmanews.com/apac/news/clinical-trials-day-2026-research-rising-oncology 2026-06-03T11:52:36.561Z weekly 0.7 https://novapharmanews.com/us/news/krystal-biotech-q1-earnings-beat-catalysts-2026-2027 2026-06-03T11:52:34.388Z weekly 0.7 https://novapharmanews.com/eu/news/efpia-warns-access-gap-us-pricing-reforms 2026-06-03T05:33:30.814Z weekly 0.7 https://novapharmanews.com/eu/news/eu-lawmakers-critical-medicines-act-deal 2026-06-03T04:56:42.215Z weekly 0.7 https://novapharmanews.com/us/news/fda-in-flux-may-2026-drug-approvals-update 2026-06-03T15:23:08.992Z weekly 0.7 https://novapharmanews.com/us/news/best-cancer-stocks-2026-investment 2026-06-03T12:28:10.313Z weekly 0.7 https://novapharmanews.com/us/news/fda-fast-track-oncology-drugs-april-2026 2026-06-03T11:52:39.853Z weekly 0.7 https://novapharmanews.com/apac/news/kelun-merck-lung-cancer-combo-china-trial 2026-06-03T11:52:34.586Z weekly 0.7 https://novapharmanews.com/us/news/liminatus-acquires-innocsai-320m-car-t-bet 2026-06-03T10:52:35.190Z weekly 0.7 https://novapharmanews.com/apac/news/ildong-pharmaceutical-stock-earnings-pipeline-insights 2026-06-03T04:57:12.212Z weekly 0.7 https://novapharmanews.com/eu/news/mhra-consultation-rare-disease-therapy 2026-06-03T04:57:04.226Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidance-animal-testing-alternatives-concerns 2026-06-03T04:57:02.221Z weekly 0.7 https://novapharmanews.com/us/news/aptar-pharma-fda-research-contract-progress 2026-06-03T04:57:00.219Z weekly 0.7 https://novapharmanews.com/eu/news/first-glp-1-gene-therapy-clinical-trial-europe 2026-06-03T15:30:22.902Z weekly 0.7 https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-biotech 2026-06-03T10:02:30.442Z weekly 0.7 https://novapharmanews.com/us/news/new-fda-guidance-ends-nicotine-pouches 2026-06-03T04:57:10.241Z weekly 0.7 https://novapharmanews.com/us/news/takeda-novartis-layoffs-pharma-impact 2026-06-03T15:36:05.139Z weekly 0.7 https://novapharmanews.com/us/news/migraine-drugmaker-reverse-merger-market-analysis 2026-06-03T12:38:52.797Z weekly 0.7 https://novapharmanews.com/us/news/fda-alert-pulmonology-drug-approvals 2026-06-03T11:13:51.990Z weekly 0.7 https://novapharmanews.com/us/news/2026-pharma-ma-breakout-year 2026-06-03T09:31:52.628Z weekly 0.7 https://novapharmanews.com/us/news/regeneron-pharma-stock-institutional-buying-insights 2026-06-03T07:13:58.696Z weekly 0.7 https://novapharmanews.com/us/news/fda-lifting-restrictions-compounded-peptides 2026-06-03T04:57:18.239Z weekly 0.7 https://novapharmanews.com/apac/news/zte-partners-china-national-clinical-research-center 2026-06-03T11:52:24.831Z weekly 0.7 https://novapharmanews.com/apac/news/novartis-pluvicto-stronger-psa-responses-prostate-cancer 2026-06-03T11:52:14.843Z weekly 0.7 https://novapharmanews.com/eu/news/february-batch-novel-medicines-ema-chmp-approval 2026-06-03T07:17:58.156Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-2026-recap 2026-06-03T16:04:24.418Z weekly 0.7 https://novapharmanews.com/us/news/thma-cpe-circle-2026-recap 2026-06-03T14:24:15.613Z weekly 0.7 https://novapharmanews.com/us/news/oct-east-coast-2026-recap 2026-06-03T11:52:38.163Z weekly 0.7 https://novapharmanews.com/eu/news/isct-2026-annual-recap 2026-06-03T04:57:44.288Z weekly 0.7 https://novapharmanews.com/us/news/sellas-nears-key-aml-data-dual-trials 2026-06-03T11:52:46.872Z weekly 0.7 https://novapharmanews.com/eu/news/global-pharmacovigilance-reporting-comparative-analysis 2026-06-03T05:48:11.990Z weekly 0.7 https://novapharmanews.com/us/news/fda-bayesian-methodology-drug-development 2026-06-03T04:57:50.286Z weekly 0.7 https://novapharmanews.com/apac/news/asia-pacific-regulatory-updates-tga-guidance 2026-06-03T10:28:58.182Z weekly 0.7 https://novapharmanews.com/eu/news/cma-deal-eu-medicine-supply-chains-analysis 2026-06-03T04:57:54.280Z weekly 0.7 https://novapharmanews.com/us/news/layoff-tracker-takeda-novartis-restructuring 2026-06-03T15:21:50.550Z weekly 0.7 https://novapharmanews.com/eu/news/x4-pharmaceuticals-ema-chmp-mavorixafor-approval 2026-06-03T14:38:00.935Z weekly 0.7 https://novapharmanews.com/eu/news/europes-drug-innovation-edge-risk-dutch-industry-group 2026-06-03T14:32:19.720Z weekly 0.7 https://novapharmanews.com/eu/news/future-european-medicine-clinical-research 2026-06-03T11:52:31.375Z weekly 0.7 https://novapharmanews.com/us/news/top-10-biopharma-ma-deals-2025 2026-06-03T04:57:56.286Z weekly 0.7 https://novapharmanews.com/eu/news/breast-cancer-experts-esmo-2026-abstracts-preview 2026-06-03T16:04:44.647Z weekly 0.7 https://novapharmanews.com/apac/news/fierce-pharma-asia-bms-hengrui-deal-takeda-layoffs 2026-06-03T11:52:43.910Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-atezolizumab-muscle-invasive-bladder-cancer 2026-06-03T11:52:39.884Z weekly 0.7 https://novapharmanews.com/apac/news/global-pharmacovigilance-reporting-regulatory-updates 2026-06-03T11:52:35.852Z weekly 0.7 https://novapharmanews.com/eu/news/q1-2026-life-sciences-law-update-clinical-trials 2026-06-03T11:52:31.164Z weekly 0.7 https://novapharmanews.com/us/news/layoff-tracker-takeda-novartis-restructure 2026-06-03T09:24:26.170Z weekly 0.7 https://novapharmanews.com/us/news/ma-in-pharmaceuticals-market-analysis 2026-06-03T09:24:20.983Z weekly 0.7 https://novapharmanews.com/apac/news/india-cdsco-prior-intimation-system-clinical-trials 2026-06-03T17:40:28.923Z weekly 0.7 https://novapharmanews.com/us/news/ucb-acquires-antibody-treatment-maker-autoimmune-disease 2026-06-03T11:52:46.870Z weekly 0.7 https://novapharmanews.com/us/news/big-pharma-ma-mega-year-patent-expiries 2026-06-03T04:58:35.827Z weekly 0.7 https://novapharmanews.com/eu/news/regulatory-round-up-may-11-2026 2026-06-03T04:58:34.386Z weekly 0.7 https://novapharmanews.com/eu/news/ema-critical-medicines-act-market-analysis 2026-06-03T04:58:32.326Z weekly 0.7 https://novapharmanews.com/apac/news/asia-bacitracin-ointment-market-analysis-regulatory-updates 2026-06-03T04:58:28.318Z weekly 0.7 https://novapharmanews.com/eu/news/eu-commission-advances-critical-medicines-act 2026-06-03T16:12:06.051Z weekly 0.7 https://novapharmanews.com/us/news/10-clinical-trials-to-watch-2026 2026-06-03T15:22:08.607Z weekly 0.7 https://novapharmanews.com/us/news/regulatory-round-up-fda-cancer-drug-approvals 2026-06-03T11:52:33.320Z weekly 0.7 https://novapharmanews.com/us/news/fda-leadership-changes-crisis-drug-approvals 2026-06-03T04:58:54.342Z weekly 0.7 https://novapharmanews.com/apac/news/the-week-in-pharma-action-reaction-insight-may-15-2026 2026-06-03T04:58:50.343Z weekly 0.7 https://novapharmanews.com/us/news/pharma-ma-roundup-april-2026 2026-06-03T04:58:44.333Z weekly 0.7 https://novapharmanews.com/eu/news/europes-biotech-dilemma-discovery-scale-clinical-trials 2026-06-03T04:58:40.327Z weekly 0.7 https://novapharmanews.com/us/news/bio-it-world-conference-2026-recap 2026-06-03T11:52:24.041Z weekly 0.7 https://novapharmanews.com/us/news/fda-approvals-cancer-drugs-may-2026 2026-06-03T14:15:44.632Z weekly 0.7 https://novapharmanews.com/us/news/makary-resigns-fda-commissioner-drug-approvals 2026-06-03T04:59:00.335Z weekly 0.7 https://novapharmanews.com/us/news/four-fda-actions-reshaping-drug-development-2026 2026-06-03T17:39:19.119Z weekly 0.7 https://novapharmanews.com/us/news/fda-oncology-drug-approvals-2026 2026-06-03T16:31:58.995Z weekly 0.7 https://novapharmanews.com/us/news/fda-policy-tracker-2026-psychedelics-regulatory-updates 2026-06-03T16:21:10.712Z weekly 0.7 https://novapharmanews.com/us/news/6-biotechs-next-ma-target 2026-06-03T14:58:08.947Z weekly 0.7 https://novapharmanews.com/us/news/biogen-acquires-apellis-pharmaceuticals-market-analysis 2026-06-03T12:26:46.738Z weekly 0.7 https://novapharmanews.com/us/news/amgen-inc-stock-lung-cancer-setback-steady-cash-flow 2026-06-03T11:52:47.556Z weekly 0.7 https://novapharmanews.com/us/news/fda-dual-approval-tdxd-her2-early-breast-cancer 2026-06-03T11:52:39.876Z weekly 0.7 https://novapharmanews.com/us/news/fda-blocks-melanoma-drug-confusion-makary 2026-06-03T06:45:35.335Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-updates-ovarian-cancer-guidelines 2026-06-03T04:59:16.357Z weekly 0.7 https://novapharmanews.com/eu/news/countries-compete-reform-trials-global-sponsors 2026-06-03T04:59:12.352Z weekly 0.7 https://novapharmanews.com/eu/news/latest-new-meds-ema-chmp-approval 2026-06-03T04:59:06.348Z weekly 0.7 https://novapharmanews.com/eu/news/20-posts-not-to-miss-esmo-breast-cancer-congress-2026 2026-06-03T13:36:00.656Z weekly 0.7 https://novapharmanews.com/apac/news/fierce-pharma-asia-bms-hengrui-takeda-daiichi 2026-06-03T11:52:43.926Z weekly 0.7 https://novapharmanews.com/apac/news/zolbetuximab-phase-2-trial-gastric-cancer 2026-06-03T10:39:12.027Z weekly 0.7 https://novapharmanews.com/eu/news/crinetics-palsonify-sales-enrollment-updates 2026-06-03T04:59:26.368Z weekly 0.7 https://novapharmanews.com/us/news/novel-drug-approvals-2026-fda 2026-06-03T17:40:20.390Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-event-daily-roundup 2026-06-03T13:42:25.168Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-event-biotech-innovation-us 2026-06-03T11:57:41.279Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-debuts-for-pharma-insights 2026-06-03T11:58:23.892Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-regulatory-preview 2026-06-03T11:52:17.064Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-regulatory-affairs-preview 2026-06-03T11:52:17.063Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-event-preview 2026-06-03T11:52:04.753Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-regulatory-conference-preview 2026-06-03T11:52:17.073Z weekly 0.7 https://novapharmanews.com/us/news/bio-it-world-conference-oncology-day-1 2026-06-03T11:57:45.395Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2024-highlights-us 2026-06-03T11:52:04.755Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-highlights-trends 2026-06-03T11:52:08.475Z weekly 0.7 https://novapharmanews.com/us/news/scope-x-2026-day-1-roundup 2026-06-03T16:22:14.351Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-biotech-research-us 2026-06-03T11:58:40.617Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-highlights-us-implications 2026-06-03T11:52:17.104Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-daily-highlights 2026-06-03T11:52:17.073Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advances 2026-06-03T11:52:17.238Z weekly 0.7 https://novapharmanews.com/us/news/oct-east-coast-daily-roundup 2026-06-03T11:52:17.244Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-highlights 2026-06-03T11:52:17.245Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-conf-2026-highlights 2026-06-03T11:52:17.261Z weekly 0.7 https://novapharmanews.com/us/news/cog-2024-highlights-trends 2026-06-03T11:52:17.285Z weekly 0.7 https://novapharmanews.com/apac/news/pda-manufacturing-apac-highlights 2026-06-03T05:00:14.428Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-highlights 2026-06-03T11:52:08.498Z weekly 0.7 https://novapharmanews.com/us/news/asgct-manufacturing-innovations-day1 2026-06-03T11:52:26.666Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements-day-1-roundup 2026-06-03T11:52:26.424Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-record-q1-revenue-wegovy-ozempic 2026-06-03T18:17:58.219Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-cost-effectiveness 2026-06-03T11:52:37.642Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day-1-roundup 2026-06-03T14:01:46.022Z weekly 0.7 https://novapharmanews.com/eu/news/isct-2026-eu-manufacturing-day-1 2026-06-03T05:00:34.867Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-day-1-gene-therapy-advancements 2026-06-03T11:52:26.425Z weekly 0.7 https://novapharmanews.com/us/news/oct-east-coast-day-1-roundup 2026-06-03T05:13:12.660Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-day1-us-biotech-trends 2026-06-03T05:14:36.029Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-biotech-innovation 2026-06-03T12:25:23.651Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-biotech-investors 2026-06-03T14:25:22.520Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-manufacturing-innovations 2026-06-03T12:00:03.586Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-conf-2026-day1-roundup 2026-06-03T11:49:10.263Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-day-1-highlights 2026-06-03T05:00:48.739Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-day-1-biotech-innovation 2026-06-03T05:00:46.459Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-day-1-roundup 2026-06-03T09:32:07.763Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day1-policy-tech 2026-06-03T05:00:51.269Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-day-1-roundup 2026-06-03T11:52:37.643Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-innovations-trends 2026-06-03T05:00:54.457Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-daily-roundup 2026-06-03T05:00:56.466Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day1 2026-06-03T05:00:58.469Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day1-highlights 2026-06-03T05:01:01.960Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-investor-roundup 2026-06-03T05:01:02.483Z weekly 0.7 https://novapharmanews.com/us/news/asgct-cell-therapy-manufacturing-innovations 2026-06-03T11:52:26.667Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-manufacturing-day-1-roundup 2026-06-03T05:01:06.463Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day-1-roundup 2026-06-03T05:01:08.475Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-day1-roundup 2026-06-03T11:52:37.655Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-investors 2026-06-03T05:01:12.471Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-day-1-highlights 2026-06-03T05:01:14.565Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-daily-roundup 2026-06-03T05:01:16.479Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-day-1 2026-06-03T05:01:18.481Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2026-manufacturing-day-1-roundup 2026-06-03T11:52:34.669Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-biotech-roundup 2026-06-03T05:01:22.488Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements-day-1 2026-06-03T15:11:35.351Z weekly 0.7 https://novapharmanews.com/us/news/thma-cpe-circle-highlights-key-trends 2026-06-03T05:01:26.499Z weekly 0.7 https://novapharmanews.com/us/news/excipient-world-conference-highlights 2026-06-03T05:01:28.494Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-highlights 2026-06-03T05:01:30.499Z weekly 0.7 https://novapharmanews.com/us/news/asgct-cell-gene-therapy-manufacturing-innovations 2026-06-03T11:52:26.675Z weekly 0.7 https://novapharmanews.com/apac/news/apac-clinical-event-preview 2026-06-03T11:52:11.047Z weekly 0.7 https://novapharmanews.com/eu/news/isct-2026-eu-manufacturing-day-1-roundup 2026-06-03T05:01:36.509Z weekly 0.7 https://novapharmanews.com/us/news/asgct-manufacturing-innovations 2026-06-03T11:52:26.675Z weekly 0.7 https://novapharmanews.com/us/news/thma-cpe-circle-daily-roundup 2026-06-03T05:01:40.525Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements 2026-06-03T11:52:26.430Z weekly 0.7 https://novapharmanews.com/us/news/thma-oncology-forum-highlights-us 2026-06-03T11:52:41.735Z weekly 0.7 https://novapharmanews.com/us/news/fdli-2026-annual-highlights 2026-06-03T13:54:24.998Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-insights 2026-06-03T05:01:48.524Z weekly 0.7 https://novapharmanews.com/us/news/aphl-2026-highlights-innovations 2026-06-03T05:01:53.621Z weekly 0.7 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-insights 2026-06-03T05:05:05.326Z weekly 0.7 https://novapharmanews.com/us/news/APHL-2026-annual-day-1-roundup 2026-06-03T05:01:54.550Z weekly 0.7 https://novapharmanews.com/us/news/aphl-2026-annual-day-1-highlights 2026-06-03T05:01:56.529Z weekly 0.7 https://novapharmanews.com/us/news/thma-oncology-forum-daily-roundup 2026-06-03T11:52:41.728Z weekly 0.7 https://novapharmanews.com/eu/news/european-research-revolution-key-takeaways 2026-06-03T05:02:06.843Z weekly 0.7 https://novapharmanews.com/us/news/ipec-annual-meeting-highlights-us 2026-06-03T05:02:02.535Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates 2026-06-03T11:52:30.998Z weekly 0.7 https://novapharmanews.com/us/news/fdli-annual-2026-daily-roundup 2026-06-03T05:02:13.073Z weekly 0.7 https://novapharmanews.com/us/news/thma-oncology-forum-day1-roundup 2026-06-03T11:52:41.728Z weekly 0.7 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-insights-policy-updates 2026-06-03T11:52:35.703Z weekly 0.7 https://novapharmanews.com/us/news/thma-oncology-forum-day-1-roundup 2026-06-03T11:52:41.730Z weekly 0.7 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-updates 2026-06-03T05:02:14.548Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-day-1-regulatory-updates 2026-06-03T11:52:31.001Z weekly 0.7 https://novapharmanews.com/eu/news/swiss-biotech-day-key-innovations-partnerships 2026-06-03T05:02:18.555Z weekly 0.7 https://novapharmanews.com/eu/news/european-research-revolution-day-1 2026-06-03T05:02:20.559Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-insights-day-1 2026-06-03T05:02:22.555Z weekly 0.7 https://novapharmanews.com/eu/news/european-research-revolution-day-1-highlights 2026-06-03T05:02:24.566Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates-day-1 2026-06-03T05:02:26.557Z weekly 0.7 https://novapharmanews.com/apac/news/cryoport-q1-2026-financial-results-clinical-trials-cell-gene-therapy 2026-06-03T11:52:22.318Z weekly 0.7 https://novapharmanews.com/apac/news/ascidian-acdn-01-stellar-trial-stargardt-disease-dose-escalation-complete 2026-06-03T16:51:45.998Z weekly 0.7 https://novapharmanews.com/apac/news/quiver-bioscience-nih-heal-grant-qv-2421-chronic-pain-trials 2026-06-03T15:19:07.532Z weekly 0.7 https://novapharmanews.com/apac/news/lunai-bioworks-20-million-cns-drug-delivery-alzheimer-treatment 2026-06-03T11:52:22.373Z weekly 0.7 https://novapharmanews.com/apac/news/stryker-australia-tga-approval-temporomandibular-joint-prosthesis 2026-06-03T18:07:40.975Z weekly 0.7 https://novapharmanews.com/apac/news/tga-section-41hd-medical-device-emergency-import-approvals-australia 2026-06-03T11:52:23.198Z weekly 0.7 https://novapharmanews.com/eu/news/biotheryx-btx-9341-phase-1a-results-esmo-breast-cancer-congress-2026 2026-06-03T17:01:33.746Z weekly 0.7 https://novapharmanews.com/us/news/palvella-qtorin-rapamycin-phase-2-trial-angiokeratomas 2026-06-03T11:52:07.263Z weekly 0.7 https://novapharmanews.com/us/news/neurocrine-biosciences-nbip-2118-phase-1-obesity-trial 2026-06-03T11:52:07.277Z weekly 0.7 https://novapharmanews.com/us/news/caplyta-lumateperone-tops-adjunctive-depression-treatments-meta-analysis 2026-06-03T11:52:07.280Z weekly 0.7 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0802-phase-2a-trial-steroid-refractory-gvhd 2026-06-03T11:52:07.282Z weekly 0.7 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0802-phase-1b-2a-trial-steroid-refractory-gvhd 2026-06-03T11:52:07.285Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-veppanu-breast-cancer-diagnostic 2026-06-03T11:52:07.288Z weekly 0.7 https://novapharmanews.com/us/news/opus-genetics-opgx-lca5-fda-rare-disease-evidence-program 2026-06-03T11:52:07.294Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-2026-day-1-roundup 2026-06-03T05:02:56.596Z weekly 0.7 https://novapharmanews.com/eu/news/heart-failure-2026-vutrisiran-data-european-pharma-news 2026-06-03T05:02:58.597Z weekly 0.7 https://novapharmanews.com/apac/news/telix-tlx250-px-zircaix-kidney-cancer-diagnosis-phase-3-zircon 2026-06-03T11:52:22.378Z weekly 0.7 https://novapharmanews.com/apac/news/arrowhead-pharmaceuticals-redemplo-plozasiran-tga-approval-australia-fcs 2026-06-03T11:52:22.193Z weekly 0.7 https://novapharmanews.com/apac/news/mifepristone-access-supreme-court-hold-planned-parenthood-5th-circuit 2026-06-03T11:52:22.412Z weekly 0.7 https://novapharmanews.com/eu/news/cvrx-benefit-hf-trial-barostim-heart-failure-first-patient 2026-06-03T11:52:28.618Z weekly 0.7 https://novapharmanews.com/eu/news/agenus-q1-2026-financial-report-botensilimab-balstilimab-update 2026-06-03T11:52:28.641Z weekly 0.7 https://novapharmanews.com/eu/news/oncolytics-biotech-pelareorep-colorectal-cancer-durable-responses 2026-06-03T11:52:28.646Z weekly 0.7 https://novapharmanews.com/eu/news/crispr-therapeutics-q1-2026-casgevy-global-approval 2026-06-03T18:10:45.099Z weekly 0.7 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-als-treatment-2024 2026-06-03T11:52:18.215Z weekly 0.7 https://novapharmanews.com/us/news/alpha-tau-alpha-dart-100-percent-disease-control-pancreatic-cancer-ddw-2026 2026-06-03T11:52:05.001Z weekly 0.7 https://novapharmanews.com/us/news/takeda-tak-881-positive-phase-2-3-results-primary-immunodeficiency-disease 2026-06-03T11:52:07.321Z weekly 0.7 https://novapharmanews.com/us/news/accord-healthcare-relaunches-tadalafil-tablets-generic-ed-treatment 2026-06-03T11:52:47.037Z weekly 0.7 https://novapharmanews.com/us/news/inspiremd-fda-approval-switchguard-neuro-protection-cguardians-iii-trial 2026-06-03T11:52:18.597Z weekly 0.7 https://novapharmanews.com/apac/news/xtalpi-pep08-prmt5-inhibitor-phase-1-cancer-trial-enrollment 2026-06-03T11:52:22.426Z weekly 0.7 https://novapharmanews.com/apac/news/spontan-phase-ii-data-10-minute-onset-fda-requirements-erectile-dysfunction 2026-06-03T11:52:22.428Z weekly 0.7 https://novapharmanews.com/apac/news/ironwood-pharmaceuticals-short-bowel-syndrome-tpn-survey-ddw-2026 2026-06-03T11:52:22.193Z weekly 0.7 https://novapharmanews.com/apac/news/edwards-lifesciences-resilia-tissue-10-year-commence-trial-results 2026-06-03T11:52:10.582Z weekly 0.7 https://novapharmanews.com/apac/news/novo-nordisk-wegovy-china-launch-eli-lilly-obesity-market 2026-06-03T08:03:36.143Z weekly 0.7 https://novapharmanews.com/apac/news/arrowhead-pharmaceuticals-tga-approval-redemplo-plozasiran-australia-fcs 2026-06-03T11:52:22.202Z weekly 0.7 https://novapharmanews.com/apac/news/biomarin-palynziq-fda-approval-adolescent-pku-patients 2026-06-03T12:51:53.456Z weekly 0.7 https://novapharmanews.com/apac/news/rois-us-expansion-global-cdmo-fda-approval-injectable-manufacturing 2026-06-03T11:52:17.459Z weekly 0.7 https://novapharmanews.com/apac/news/fda-approves-travere-filspari-fsgs-treatment-adults-children 2026-06-03T11:52:22.226Z weekly 0.7 https://novapharmanews.com/eu/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-launch 2026-06-03T11:52:28.647Z weekly 0.7 https://novapharmanews.com/eu/news/takeda-tak-881-phase-3-trial-primary-immunodeficiency-disease-results 2026-06-03T11:52:28.666Z weekly 0.7 https://novapharmanews.com/eu/news/pulse-biosciences-atrial-fibrillation-treatment-100-percent-success-rate-2026 2026-06-03T11:52:28.702Z weekly 0.7 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-subcut-hf-ii-trial-results-heart-failure-2026 2026-06-03T11:52:28.729Z weekly 0.7 https://novapharmanews.com/eu/news/krystal-biotech-q1-2026-results-vyjuvek-expansion-registrational-studies 2026-06-03T11:52:28.730Z weekly 0.7 https://novapharmanews.com/eu/news/acurx-dna-pol-iiic-inhibitors-microbiome-preservation-mrsa-escmid-2026 2026-06-03T11:52:28.753Z weekly 0.7 https://novapharmanews.com/eu/news/biocryst-navenibart-european-licensing-deal-neopharmed-gentili 2026-06-03T11:52:28.755Z weekly 0.7 https://novapharmanews.com/eu/news/biosimulation-market-11-billion-2031-drug-development 2026-06-03T11:52:43.792Z weekly 0.7 https://novapharmanews.com/eu/news/grin-therapeutics-phase-3-beeline-study-radiprodil-europe-grin-ndd 2026-06-03T11:52:29.861Z weekly 0.7 https://novapharmanews.com/eu/news/fda-approves-langlara-biosimilar-lantus-insulin-lannett-company 2026-06-03T11:52:30.051Z weekly 0.7 https://novapharmanews.com/eu/news/vertex-casgevy-gene-therapy-global-expansion-q1-2026-results 2026-06-03T18:08:22.898Z weekly 0.7 https://novapharmanews.com/eu/news/oncolytics-biotech-pelareorep-durable-responses-ras-mutant-colorectal-cancer 2026-06-03T11:52:32.109Z weekly 0.7 https://novapharmanews.com/eu/news/nuvation-bio-ibtrozi-q1-2026-revenue-ros1-nsclc 2026-06-03T15:29:16.985Z weekly 0.7 https://novapharmanews.com/us/news/crispr-therapeutics-casgevy-global-approvals-60000-patients 2026-06-03T12:22:35.618Z weekly 0.7 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-pathway-als-treatment 2026-06-03T11:52:18.624Z weekly 0.7 https://novapharmanews.com/us/news/atossa-therapeutics-fda-rare-pediatric-disease-designation-z-endoxifen-mccune-albright-syndrome 2026-06-03T11:52:27.995Z weekly 0.7 https://novapharmanews.com/us/news/mbiota-elemental-ibs-treatment-ddw-2026-clinical-trial 2026-06-03T11:52:28.006Z weekly 0.7 https://novapharmanews.com/us/news/novartis-fabhalta-health-canada-approval-c3g-treatment 2026-06-03T11:52:18.626Z weekly 0.7 https://novapharmanews.com/us/news/asco-2026-cellectar-waldenstrom-macroglobulinemia 2026-06-03T11:52:22.185Z weekly 0.7 https://novapharmanews.com/us/news/alpha-tau-alpha-dart-pancreatic-cancer-trials-ddw-2026 2026-06-03T11:52:05.002Z weekly 0.7 https://novapharmanews.com/us/news/cytokinetics-aficamten-phase-3-trial-results-non-obstructive-hypertrophic-cardiomyopathy-may-2026 2026-06-03T17:14:43.666Z weekly 0.7 https://novapharmanews.com/us/news/inflarx-izicopan-reactive-metabolite-liver-safety-study 2026-06-03T11:52:17.223Z weekly 0.7 https://novapharmanews.com/us/news/macrogenics-expands-zynyz-royalty-agreement-sagard-healthcare 2026-06-03T11:52:28.138Z weekly 0.7 https://novapharmanews.com/us/news/akebia-vadadustat-mortality-reduction-kidney-disease-jasn-study 2026-06-03T11:52:18.630Z weekly 0.7 https://novapharmanews.com/us/news/inflarx-izicopan-favorable-liver-metabolism-safety-profile-2026 2026-06-03T12:07:15.453Z weekly 0.7 https://novapharmanews.com/us/news/celcuity-gedatolisib-phase-3-viktoria-1-trial-pik3ca-mutant-cancer 2026-06-03T11:52:13.894Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-langlara-interchangeable-biosimilar-lantus-insulin-lannett 2026-06-03T11:52:11.367Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-companion-diagnostic-pfizer-veppanu-breast-cancer 2026-06-03T11:52:09.299Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis 2026-06-03T16:10:02.647Z weekly 0.7 https://novapharmanews.com/us/news/arvinas-veppanu-vepdegestrant-fda-approval-first-protac-drug-esr1-breast-cancer 2026-06-03T17:43:18.823Z weekly 0.7 https://novapharmanews.com/us/news/excipient-world-conference-daily-roundup 2026-06-03T05:04:42.753Z weekly 0.7 https://novapharmanews.com/us/news/APHL-2026-annual-meeting-day-1-highlights 2026-06-03T05:04:47.862Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-day-1-roundup 2026-06-03T08:14:20.484Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-daily-roundup 2026-06-03T05:04:48.764Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-new-mdd-treatment 2026-06-03T11:52:09.858Z monthly 0.5 https://novapharmanews.com/apac/news/sun-pharma-organon-partnership-india 2026-06-03T11:52:14.843Z monthly 0.5 https://novapharmanews.com/eu/news/fda-approves-auvelity-mdd-axsome-therapeutics 2026-06-03T11:52:11.371Z monthly 0.5 https://novapharmanews.com/eu/news/purdue-pharma-shutdown-oxycontin-settlement 2026-06-03T11:52:17.754Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-palazestrant-pfizer-arvinas-breast-cancer-drug 2026-06-03T11:52:32.892Z monthly 0.5 https://novapharmanews.com/eu/news/eular-2026-immutep-imp761-phase-1-preview 2026-06-03T14:00:12.340Z monthly 0.5 https://novapharmanews.com/us/news/thma-pharmacy-growth-priorities-2026 2026-06-03T11:52:12.083Z monthly 0.5 https://novapharmanews.com/us/news/cphi-americas-2026-pharma-manufacturing-trends 2026-06-03T14:00:08.492Z monthly 0.5 https://novapharmanews.com/us/news/ipec-americas-annual-meeting-daily-roundup 2026-06-03T05:05:06.788Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-day-1-highlights 2026-06-03T05:05:08.779Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-day-1-roundup 2026-06-03T12:33:20.724Z monthly 0.5 https://novapharmanews.com/apac/news/ucb-acquires-candid-therapeutics-2-2-billion-t-cell-engager-autoimmune 2026-06-03T11:52:23.742Z monthly 0.5 https://novapharmanews.com/eu/news/novelty-nobility-agc-biologics-bispecific-antibody-manufacturing-partnership 2026-06-03T11:52:19.032Z monthly 0.5 https://novapharmanews.com/eu/news/smartee-denti-technology-mandibular-repositioning-eas-congress-2026 2026-06-03T11:52:33.464Z monthly 0.5 https://novapharmanews.com/us/news/xtalpi-pep08-prmt5-inhibitor-phase-1-cancer-trial-enrollment 2026-06-03T14:39:39.034Z monthly 0.5 https://novapharmanews.com/us/news/mirum-pharmaceuticals-vistas-volixibat-primary-sclerosing-cholangitis-results-may-2026 2026-06-03T12:03:03.840Z monthly 0.5 https://novapharmanews.com/us/news/everads-therapy-suprachoroidal-injector-clinical-data-ophthalmology-science 2026-06-03T11:52:27.263Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-candid-therapeutics-autoimmune-deal 2026-06-03T11:52:17.230Z monthly 0.5 https://novapharmanews.com/us/news/spinogenix-tazbentetol-neuroprotective-glaucoma-diabetic-retinopathy-arvo-2026 2026-06-03T11:52:18.631Z monthly 0.5 https://novapharmanews.com/us/news/niktimvo-axatilimab-approved-australia-chronic-gvhd-treatment 2026-06-03T11:52:17.247Z monthly 0.5 https://novapharmanews.com/us/news/ipec-annual-meeting-2026-no-pharma-news 2026-06-03T05:05:30.797Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-ai-oncology-microbiome 2026-06-03T05:05:38.128Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-2026-daily-roundup 2026-06-03T12:18:23.949Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-meeting-opens-public-health-lab-focus 2026-06-03T05:05:36.809Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-mdd-new-antidepressant 2026-06-03T14:49:12.337Z monthly 0.5 https://novapharmanews.com/eu/news/purdue-pharma-dissolution-approved-opioid-crisis 2026-06-03T11:52:42.800Z monthly 0.5 https://novapharmanews.com/eu/news/auvelity-fda-approval-axsome-therapeutics 2026-06-03T11:52:35.668Z monthly 0.5 https://novapharmanews.com/us/news/axsome-fda-approval-alzheimers-agitation 2026-06-03T11:52:17.762Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-first-non-antipsychotic-dementia-agitation 2026-06-03T15:51:13.286Z monthly 0.5 https://novapharmanews.com/apac/news/a2-milk-company-recalls-platinum-infant-formula-health-risk 2026-06-03T17:54:17.008Z monthly 0.5 https://novapharmanews.com/us/news/edwards-lifesciences-resilia-tissue-10-year-durability-aortic-valve-trial 2026-06-03T12:19:48.081Z monthly 0.5 https://novapharmanews.com/us/news/biomarin-voxzogo-achondroplasia-long-term-data-pes-2026 2026-06-03T14:48:45.847Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis-polycythemia-vera 2026-06-03T12:12:51.116Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-axsome-therapeutics-mdd 2026-06-03T11:52:33.724Z monthly 0.5 https://novapharmanews.com/eu/news/fda-approves-auvelity-for-major-depressive-disorder 2026-06-03T11:52:35.679Z monthly 0.5 https://novapharmanews.com/us/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-06-03T05:06:00.839Z monthly 0.5 https://novapharmanews.com/apac/news/vector-science-therapeutics-microneedle-catheter-patent-intratumoral-drug-delivery 2026-06-03T11:52:23.199Z monthly 0.5 https://novapharmanews.com/apac/news/apotex-generic-ozempic-semaglutide-health-canada-approval-2026 2026-06-03T16:56:54.682Z monthly 0.5 https://novapharmanews.com/apac/news/keenova-terlivaz-terlipressin-clinical-data-digestive-disease-week-2026 2026-06-03T14:48:52.596Z monthly 0.5 https://novapharmanews.com/apac/news/kodiak-sciences-ksi-101-clinical-data-macular-edema-conferences 2026-06-03T11:52:23.742Z monthly 0.5 https://novapharmanews.com/eu/news/synbiotech-microbiome-womens-healthy-aging-vitafoods-2026 2026-06-03T05:06:10.859Z monthly 0.5 https://novapharmanews.com/eu/news/curaleaf-torsten-greif-board-appointment-european-cannabis 2026-06-03T05:06:12.854Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-manufacturing-software-market-787-billion-2030 2026-06-03T11:52:19.035Z monthly 0.5 https://novapharmanews.com/eu/news/goodrx-ozempic-pill-type-2-diabetes-149-monthly 2026-06-03T05:06:16.867Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-crenessity-two-year-pediatric-cah-study-results 2026-06-03T11:52:17.765Z monthly 0.5 https://novapharmanews.com/us/news/cairn-surgical-breast-cancer-locator-system-pivotal-trial-results 2026-06-03T11:52:05.028Z monthly 0.5 https://novapharmanews.com/us/news/restore-vision-rv-001-gene-therapy-retinitis-pigmentosa-clinical-results 2026-06-03T11:52:27.501Z monthly 0.5 https://novapharmanews.com/us/news/archimed-acquires-esperion-therapeutics-cardiometabolic-deal-2026 2026-06-03T16:34:00.202Z monthly 0.5 https://novapharmanews.com/us/news/oculis-dme-research-arvo-2026-presentation 2026-06-03T11:52:34.931Z monthly 0.5 https://novapharmanews.com/us/news/rhythm-pharmaceuticals-imcivree-european-commission-approval-hypothalamic-obesity 2026-06-03T11:52:18.632Z monthly 0.5 https://novapharmanews.com/us/news/atara-biotherapeutics-ebvallo-fda-complete-response-letter-securities-lawsuit 2026-06-03T15:12:58.664Z monthly 0.5 https://novapharmanews.com/us/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-available 2026-06-03T11:52:18.634Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-oral-ozempic-fda-approved-pill-glp1-type-2-diabetes-cardiovascular 2026-06-03T11:52:11.367Z monthly 0.5 https://novapharmanews.com/us/news/zeta-surgical-fda-clearance-brain-surgery-navigation-system 2026-06-03T11:52:18.635Z monthly 0.5 https://novapharmanews.com/us/news/viatris-low-dose-estrogen-contraceptive-patch-acog-2026 2026-06-03T17:45:35.267Z monthly 0.5 https://novapharmanews.com/us/news/axsome-auvelity-fda-approval-alzheimers-agitation-treatment 2026-06-03T11:52:43.814Z monthly 0.5 https://novapharmanews.com/us/news/incyte-jakafi-xr-fda-approval-myelofibrosis-polycythemia-vera-gvhd 2026-06-03T11:52:17.257Z monthly 0.5 https://novapharmanews.com/us/news/arvinas-fda-approval-veppanu-vepdegestrant-protac-esr1-breast-cancer 2026-06-03T17:40:08.774Z monthly 0.5 https://novapharmanews.com/apac/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-06-03T11:52:33.736Z monthly 0.5 https://novapharmanews.com/eu/news/plozasiran-tga-approval-australia-fcs 2026-06-03T05:06:48.890Z monthly 0.5 https://novapharmanews.com/us/news/moderna-fda-talks-phase-4-covid-vaccine-data 2026-06-03T05:06:50.890Z monthly 0.5 https://novapharmanews.com/apac/news/namsa-lexitas-partnership-ophthalmic-medical-device-development 2026-06-03T11:52:23.203Z monthly 0.5 https://novapharmanews.com/apac/news/verified-clinical-trials-chubb-partnership-patient-safety-data-quality 2026-06-03T05:06:56.898Z monthly 0.5 https://novapharmanews.com/apac/news/huahui-health-beone-medicines-hh160-trispecific-antibody-oncology-partnership 2026-06-03T05:06:58.895Z monthly 0.5 https://novapharmanews.com/apac/news/amgen-q1-2026-financial-results-double-digit-growth 2026-06-03T17:13:06.808Z monthly 0.5 https://novapharmanews.com/apac/news/haier-biomedical-international-revenue-growth-2025 2026-06-03T11:52:42.654Z monthly 0.5 https://novapharmanews.com/apac/news/tga-combination-boundary-products-guidance-apac-pharmaceutical 2026-06-03T11:52:23.203Z monthly 0.5 https://novapharmanews.com/apac/news/genprex-israel-patent-reqorsa-gene-therapy-pd1-antibodies-cancer 2026-06-03T11:52:23.287Z monthly 0.5 https://novapharmanews.com/apac/news/prolacta-human-milk-fortifiers-prescription-drug-status-japan-jasmine-trial 2026-06-03T13:35:43.626Z monthly 0.5 https://novapharmanews.com/eu/news/stoke-therapeutics-zorevunersen-dravet-syndrome-q1-2026-results 2026-06-03T18:02:47.425Z monthly 0.5 https://novapharmanews.com/eu/news/uniqure-amt-130-gene-therapy-uk-approval-huntingtons-disease 2026-06-03T11:52:28.811Z monthly 0.5 https://novapharmanews.com/eu/news/northwest-biotherapeutics-annalisa-jenkins-dcvax-cancer-vaccine-adviser 2026-06-03T05:07:15.005Z monthly 0.5 https://novapharmanews.com/eu/news/cerus-intercept-blood-system-european-regulatory-review-phase-3-trials 2026-06-03T11:52:33.551Z monthly 0.5 https://novapharmanews.com/eu/news/bio-rad-q1-2026-ivdr-compliance-costs-european-diagnostics 2026-06-03T11:52:45.124Z monthly 0.5 https://novapharmanews.com/eu/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-06-03T05:07:20.923Z monthly 0.5 https://novapharmanews.com/eu/news/alkeus-gildeuretinol-stargardt-disease-arvo-2026-data 2026-06-03T17:52:09.445Z monthly 0.5 https://novapharmanews.com/eu/news/setpoint-medical-multiple-sclerosis-trial-neuroimmune-therapy 2026-06-03T11:52:29.865Z monthly 0.5 https://novapharmanews.com/eu/news/emergent-biosolutions-q1-2026-financial-results 2026-06-03T05:07:26.924Z monthly 0.5 https://novapharmanews.com/eu/news/telix-tlx101-px-pixlumi-brain-cancer-imaging-european-approval 2026-06-03T11:52:29.879Z monthly 0.5 https://novapharmanews.com/us/news/mrm-health-mh002-fda-fast-track-ulcerative-colitis 2026-06-03T11:52:17.257Z monthly 0.5 https://novapharmanews.com/us/news/cadrenal-therapeutics-cad-1005-fda-phase-3-heparin-induced-thrombocytopenia 2026-06-03T11:52:17.256Z monthly 0.5 https://novapharmanews.com/us/news/redhill-rhb-204-comparable-efficacy-rhb-104-crohns-disease-map-treatment 2026-06-03T11:52:17.286Z monthly 0.5 https://novapharmanews.com/us/news/phathom-pharmaceuticals-voquezna-q1-2026-earnings-profitability-guidance 2026-06-03T11:52:44.394Z monthly 0.5 https://novapharmanews.com/us/news/contineum-therapeutics-pipe-791-positive-phase-1b-chronic-pain-results 2026-06-03T17:10:09.000Z monthly 0.5 https://novapharmanews.com/us/news/summit-therapeutics-ivonescimab-overall-survival-lung-cancer-asco-2026 2026-06-03T17:49:09.010Z monthly 0.5 https://novapharmanews.com/us/news/ac-immune-aci-24-alzheimers-trial-final-cohort-aci-19764-phase-1 2026-06-03T11:52:28.317Z monthly 0.5 https://novapharmanews.com/us/news/addex-dipraglurant-brain-injury-recovery-2025-results 2026-06-03T11:52:44.544Z monthly 0.5 https://novapharmanews.com/us/news/ac-immune-final-cohort-abate-trial-anti-abeta-alzheimer-treatment 2026-06-03T11:52:44.624Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-cervical-cancer-esmo-gc-2026 2026-06-03T11:52:19.090Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-securities-fraud-lawsuit-anaphylm-fda-review 2026-06-03T13:26:27.979Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-ankt-lawsuit-2026 2026-06-03T12:23:30.189Z monthly 0.5 https://novapharmanews.com/us/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-06-03T11:52:33.989Z monthly 0.5 https://novapharmanews.com/us/news/eli-lilly-foundayo-orforglipron-fda-approval-obesity-q1-2026-results 2026-06-03T17:59:52.022Z monthly 0.5 https://novapharmanews.com/us/news/theradaptive-fda-approval-osteoadapt-sp-phase-3-spinal-fusion-trial 2026-06-03T11:52:45.040Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-ai-gene-therapy 2026-06-03T13:44:17.500Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-q1-2026-licensing-deals 2026-06-03T17:46:43.357Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-2026-ai-oncology-preview 2026-06-03T18:06:30.646Z monthly 0.5 https://novapharmanews.com/us/news/ipec-excipient-world-biologics-summit-2026-preview 2026-06-03T16:12:27.049Z monthly 0.5 https://novapharmanews.com/apac/news/axoft-55m-series-a-brain-computer-interface-clinical-trials 2026-06-03T11:52:23.421Z monthly 0.5 https://novapharmanews.com/apac/news/vivacta-bio-50-million-series-a-funding-gt801-car-t-therapy 2026-06-03T17:30:16.052Z monthly 0.5 https://novapharmanews.com/apac/news/taimei-technology-ai-clinical-trials-biokorea-2026 2026-06-03T05:08:13.087Z monthly 0.5 https://novapharmanews.com/apac/news/energenesis-energi-f703dfu-diabetic-foot-ulcer-ewma-2026 2026-06-03T08:10:33.729Z monthly 0.5 https://novapharmanews.com/apac/news/ascletis-pharma-diabetes-drug-data-ada-2026-scientific-sessions 2026-06-03T05:08:17.087Z monthly 0.5 https://novapharmanews.com/apac/news/tlx597-tx-psma-radioligand-therapy-optimal-trial-prostate-cancer 2026-06-03T05:08:19.099Z monthly 0.5 https://novapharmanews.com/apac/news/immunitybio-securities-fraud-lawsuit-anktiva-fda-warning-letter 2026-06-03T14:20:40.765Z monthly 0.5 https://novapharmanews.com/eu/news/hutchmed-sovleplenib-priority-review-breakthrough-designation-china-autoimmune-hemolytic-anemia 2026-06-03T11:52:28.815Z monthly 0.5 https://novapharmanews.com/eu/news/fda-real-world-evidence-framework-medtech-ventripoint-10-billion 2026-06-03T14:09:26.048Z monthly 0.5 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug-700-million 2026-06-03T13:55:22.985Z monthly 0.5 https://novapharmanews.com/us/news/purespring-therapeutics-nphs2-genetic-variants-adult-onset-fsgs-study 2026-06-03T12:13:32.279Z monthly 0.5 https://novapharmanews.com/us/news/viking-therapeutics-vk2735-phase-3-obesity-trials-enrolled-q1-2026 2026-06-03T12:50:42.003Z monthly 0.5 https://novapharmanews.com/us/news/relay-therapeutics-q1-2026-earnings-zovegalisib-updates-may-5 2026-06-03T16:04:28.731Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-ingrezza-tardive-dyskinesia-improvement-threshold-study 2026-06-03T11:52:17.785Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-denecimig-hemophilia-a-phase-3-trial-nejm 2026-06-03T11:52:47.333Z monthly 0.5 https://novapharmanews.com/us/news/addex-gabab-pam-ipf-chronic-cough-preclinical-results 2026-06-03T11:52:44.731Z monthly 0.5 https://novapharmanews.com/us/news/iga-nephropathy-market-forecast-2036-novartis-zigakibart-immunotherapies 2026-06-03T11:52:29.553Z monthly 0.5 https://novapharmanews.com/us/news/perimeter-medical-claire-oct-ai-fda-approval-breast-cancer-surgery 2026-06-03T11:52:18.787Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-q1-2026-earnings-dupixent-eylea-hd-sales-growth 2026-06-03T16:22:56.431Z monthly 0.5 https://novapharmanews.com/us/news/sprout-pharmaceuticals-addyi-flibanserin-time-top-10-influential-health-companies-2026 2026-06-03T11:52:44.403Z monthly 0.5 https://novapharmanews.com/eu/news/biopharma-clinical-trials-eu-daily-insights 2026-06-03T05:08:49.135Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-2026-key-takeaways 2026-06-03T15:30:24.059Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026-key-takeaways 2026-06-03T16:48:03.993Z monthly 0.5 https://novapharmanews.com/us/news/ieee-cog-2026-industry-day-game-dev-tutorials 2026-06-03T05:08:55.147Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-highlights 2026-06-03T12:51:11.201Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-dealmaking 2026-06-03T05:08:59.134Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-pharma-takeaways 2026-06-03T05:09:01.139Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-apac 2026-06-03T05:09:03.138Z monthly 0.5 https://novapharmanews.com/apac/news/insilico-rentosertib-inhalation-ind-clearance-ai-drug-clinical-trial 2026-06-03T17:51:00.832Z monthly 0.5 https://novapharmanews.com/apac/news/thailand-asean-medical-device-market-gateway-2029 2026-06-03T15:16:40.554Z monthly 0.5 https://novapharmanews.com/apac/news/yangtze-river-pharmaceutical-group-international-revenue-growth-2025 2026-06-03T12:27:16.528Z monthly 0.5 https://novapharmanews.com/apac/news/soleno-therapeutics-securities-fraud-lawsuit-phase-3-clinical-trials 2026-06-03T07:06:51.411Z monthly 0.5 https://novapharmanews.com/apac/news/newleos-ntx-2001-phase-1b-trial-alcohol-use-disorder 2026-06-03T11:52:23.445Z monthly 0.5 https://novapharmanews.com/apac/news/citius-oncology-lymphir-first-international-shipment-europe 2026-06-03T14:47:20.326Z monthly 0.5 https://novapharmanews.com/apac/news/eirgenix-japan-biosimilar-expansion-cphi-2026 2026-06-03T11:52:22.967Z monthly 0.5 https://novapharmanews.com/eu/news/european-commission-approves-poherdy-pertuzumab-biosimilar-henlius-organon 2026-06-03T18:14:30.106Z monthly 0.5 https://novapharmanews.com/eu/news/puretech-lyt-200-clinical-results-myeloid-malignancies-2025 2026-06-03T05:09:21.161Z monthly 0.5 https://novapharmanews.com/eu/news/enterobiotix-19m-funding-phase-2b-ibs-microbiome-trial 2026-06-03T11:30:00.848Z monthly 0.5 https://novapharmanews.com/eu/news/ray-therapeutics-rtx-015-ema-prime-designation-retinitis-pigmentosa 2026-06-03T11:52:28.864Z monthly 0.5 https://novapharmanews.com/eu/news/x4-pharmaceuticals-xolremdi-mavorixafor-european-approval-whim-syndrome 2026-06-03T12:23:36.129Z monthly 0.5 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-whim-syndrome-european-approval 2026-06-03T12:26:44.650Z monthly 0.5 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-european-approval-whim-syndrome-treatment 2026-06-03T12:26:45.793Z monthly 0.5 https://novapharmanews.com/eu/news/ema-expert-panel-covid-19-mrna-vaccine-trust-spikevax-comirnaty 2026-06-03T12:50:53.958Z monthly 0.5 https://novapharmanews.com/eu/news/henlius-organon-poherdy-first-pertuzumab-biosimilar-approved-europe 2026-06-03T13:09:21.744Z monthly 0.5 https://novapharmanews.com/us/news/fda-clinical-hold-newron-evenamide-phase-3-trial-treatment-resistant-schizophrenia 2026-06-03T11:52:32.608Z monthly 0.5 https://novapharmanews.com/us/news/teva-q1-2026-results-ponlimsi-fda-approval-olanzapine-lai 2026-06-03T12:37:16.738Z monthly 0.5 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug 2026-06-03T11:52:44.732Z monthly 0.5 https://novapharmanews.com/us/news/teva-ponlimsi-biosimilar-fda-approval-prolia-q1-2026-results 2026-06-03T11:52:16.929Z monthly 0.5 https://novapharmanews.com/us/news/bayer-asundexian-stroke-trial-esoc-2026-abstracts 2026-06-03T18:06:54.969Z monthly 0.5 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-multiple-myeloma-isct-2026 2026-06-03T15:12:57.350Z monthly 0.5 https://novapharmanews.com/us/news/pfizer-elrexfio-progression-free-survival-multiple-myeloma-phase-3-trial 2026-06-03T15:14:09.633Z monthly 0.5 https://novapharmanews.com/us/news/rein-therapeutics-lti-03-phase-2-trial-enrollment-update-ipf 2026-06-03T11:52:17.898Z monthly 0.5 https://novapharmanews.com/us/news/laguna-biotherapeutics-fda-clearance-lgna-100-pediatric-leukemia-trial 2026-06-03T11:52:45.049Z monthly 0.5 https://novapharmanews.com/us/news/expression-therapeutics-fda-fast-track-hemophilia-a-stem-cell-therapy 2026-06-03T11:52:27.502Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-gilead-bictegravir-lenacapavir-hiv-treatment 2026-06-03T16:57:44.325Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-otarmeni-gene-therapy-free-hearing-loss-government-agreement 2026-06-03T11:52:27.506Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-daily-roundup 2026-06-03T05:10:01.204Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals 2026-06-03T05:10:07.886Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-daily-highlights 2026-06-03T05:10:05.212Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-investment 2026-06-03T05:10:07.202Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-oncology-data-readouts 2026-06-03T18:11:22.439Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-oncology-trials-preview 2026-06-03T18:03:52.312Z monthly 0.5 https://novapharmanews.com/us/news/fda-redi-conference-2026-regulatory-strategies 2026-06-03T11:52:26.867Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-daily-insights 2026-06-03T05:10:15.214Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-investment 2026-06-03T05:10:17.214Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-day-1 2026-06-03T05:10:19.215Z monthly 0.5 https://novapharmanews.com/apac/news/trialcliniq-150k-investment-caduceus-capital-ai-clinical-trial-recruitment 2026-06-03T12:28:34.889Z monthly 0.5 https://novapharmanews.com/apac/news/argo-biopharma-bw-50218-phase-1-trial-first-patient-sirna-therapy 2026-06-03T11:52:22.250Z monthly 0.5 https://novapharmanews.com/apac/news/claruvis-retoxin-first-recombinant-botulinum-toxin-approval-china 2026-06-03T11:52:23.448Z monthly 0.5 https://novapharmanews.com/apac/news/jyong-biotech-botreso-botanical-drug-market-access-strategy-2026 2026-06-03T09:19:28.484Z monthly 0.5 https://novapharmanews.com/apac/news/arcera-life-sciences-fosun-pharma-neurodegenerative-disease-collaboration 2026-06-03T11:52:23.447Z monthly 0.5 https://novapharmanews.com/apac/news/samsung-bioepis-atlatl-partnership-asia-pacific-biotech-innovation 2026-06-03T08:46:02.564Z monthly 0.5 https://novapharmanews.com/apac/news/tga-implantable-medical-devices-regulatory-framework-australia-2024 2026-06-03T13:31:04.841Z monthly 0.5 https://novapharmanews.com/apac/news/immunic-appoints-michael-panzara-chief-medical-officer-vidofludimus-calcium 2026-06-03T17:40:28.686Z monthly 0.5 https://novapharmanews.com/apac/news/zhengye-biotechnology-fiscal-2025-financial-results-veterinary-vaccines 2026-06-03T11:31:19.404Z monthly 0.5 https://novapharmanews.com/eu/news/vivosim-labs-ai-tool-predicts-drug-diarrhea-without-animal-testing 2026-06-03T06:58:15.369Z monthly 0.5 https://novapharmanews.com/eu/news/boehringer-ingelheim-survodutide-weight-loss-phase-2-trial-results 2026-06-03T05:10:41.244Z monthly 0.5 https://novapharmanews.com/eu/news/idorsia-quviviq-74-percent-sales-growth-q1-2026-european-expansion 2026-06-03T11:52:29.897Z monthly 0.5 https://novapharmanews.com/eu/news/small-molecule-api-market-202-billion-2036-generic-drugs 2026-06-03T11:52:19.037Z monthly 0.5 https://novapharmanews.com/eu/news/silexion-therapeutics-sil204-phase-2-3-trial-kras-pancreatic-cancer 2026-06-03T15:55:50.045Z monthly 0.5 https://novapharmanews.com/eu/news/novo-nordisk-wegovy-data-women-obesity-european-congress-2026 2026-06-03T15:04:43.816Z monthly 0.5 https://novapharmanews.com/eu/news/solid-biosciences-sgt-003-european-orphan-drug-designation-duchenne-muscular-dystrophy 2026-06-03T11:52:29.904Z monthly 0.5 https://novapharmanews.com/eu/news/cytokinetics-myqorzo-aficamten-esc-heart-failure-2026-congress 2026-06-03T10:04:33.723Z monthly 0.5 https://novapharmanews.com/eu/news/artiva-biotherapeutics-allonk-fda-fast-track-rheumatoid-arthritis 2026-06-03T11:52:32.125Z monthly 0.5 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-ce-marking-approval-european-market 2026-06-03T11:52:33.581Z monthly 0.5 https://novapharmanews.com/us/news/aop-health-rapiblyk-landiolol-first-patient-treatment-us 2026-06-03T15:29:46.694Z monthly 0.5 https://novapharmanews.com/us/news/emergent-biosolutions-substipharm-japanese-encephalitis-vaccine-manufacturing-partnership 2026-06-03T11:52:18.374Z monthly 0.5 https://novapharmanews.com/us/news/cordis-selution-slr-drug-eluting-balloon-japan-launch 2026-06-03T12:50:55.333Z monthly 0.5 https://novapharmanews.com/us/news/zealand-pharma-survodutide-weight-loss-phase-3-trial-results 2026-06-03T11:52:28.307Z monthly 0.5 https://novapharmanews.com/us/news/ashvattha-therapeutics-migaldendranib-diabetic-macular-edema-amd-data 2026-06-03T12:50:46.772Z monthly 0.5 https://novapharmanews.com/us/news/aclaris-ati-052-phase-1a-trial-results-45-day-half-life 2026-06-03T13:17:51.964Z monthly 0.5 https://novapharmanews.com/us/news/trevi-therapeutics-q1-2026-earnings-haduvio-chronic-cough-updates 2026-06-03T06:58:58.594Z monthly 0.5 https://novapharmanews.com/us/news/soligenix-hybryte-phase-3-flash2-trial-interim-results-ctcl 2026-06-03T12:38:39.834Z monthly 0.5 https://novapharmanews.com/us/news/avicanna-us-cannabis-rescheduling-medical-research-development 2026-06-03T11:52:34.944Z monthly 0.5 https://novapharmanews.com/us/news/innocare-orelabrutinib-phase-3-trial-sle-treatment 2026-06-03T11:52:42.269Z monthly 0.5 https://novapharmanews.com/us/news/orca-bio-orca-q-fda-rmat-designation-blood-cancers 2026-06-03T09:12:24.729Z monthly 0.5 https://novapharmanews.com/us/news/formblends-2026-peptide-report-rfk-hhs-glp1-therapy-access 2026-06-03T11:52:46.503Z monthly 0.5 https://novapharmanews.com/us/news/c-ray-therapeutics-fda-copper-64-drug-master-file-approval 2026-06-03T11:52:32.611Z monthly 0.5 https://novapharmanews.com/us/news/brc-therapeutics-fda-clearance-brc-002-phase-1-trial-crps 2026-06-03T11:52:42.888Z monthly 0.5 https://novapharmanews.com/us/news/vanda-pharmaceuticals-imsidolimab-generalized-pustular-psoriasis-nejm-evidence 2026-06-03T14:21:48.330Z monthly 0.5 https://novapharmanews.com/us/news/astrazeneca-breztri-aerosphere-approved-first-triple-therapy-asthma-patients-12-older 2026-06-03T14:50:46.166Z monthly 0.5 https://novapharmanews.com/us/news/vensica-medical-fda-ind-approval-vixe-xeomin-needle-free-delivery-overactive-bladder 2026-06-03T11:52:27.261Z monthly 0.5 https://novapharmanews.com/us/news/abbvie-upadacitinib-rinvoq-fda-application-alopecia-areata 2026-06-03T11:52:32.610Z monthly 0.5 https://novapharmanews.com/us/news/novartis-q1-2026-earnings-remibrutinib-chmp-approval-pipeline-growth 2026-06-03T16:48:37.646Z monthly 0.5 https://novapharmanews.com/us/news/wave-life-sciences-wve-007-phase-2a-fda-approval-obesity-diabetes 2026-06-03T13:15:00.518Z monthly 0.5 https://novapharmanews.com/eu/news/biopharma-clinical-trials-daily-roundup 2026-06-03T05:11:39.300Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-emergent-evolveimmune-deals 2026-06-03T05:11:47.190Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-deal-surge-lilly-sun 2026-06-03T05:11:43.324Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-investment-trends 2026-06-03T05:11:45.306Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-annex-1-challenges 2026-06-03T11:52:42.166Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-day-1-highlights 2026-06-03T05:11:49.303Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-event-day-1 2026-06-03T11:52:39.443Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-daily-roundup 2026-06-03T05:11:54.572Z monthly 0.5 https://novapharmanews.com/us/news/ascrs-2026-opus-genetics-phentolamine-preview 2026-06-03T05:11:55.321Z monthly 0.5 https://novapharmanews.com/us/news/fdli-2026-fda-strategic-priorities 2026-06-03T07:52:09.978Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-day-1-roundup 2026-06-03T05:12:02.744Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-2026-daily-roundup 2026-06-03T11:52:44.128Z monthly 0.5 https://novapharmanews.com/apac/news/akso-health-group-brain-computer-interface-rd-program-neurotechnology 2026-06-03T11:52:23.239Z monthly 0.5 https://novapharmanews.com/apac/news/evofem-solosec-distribution-agreement-sub-saharan-africa 2026-06-03T05:49:27.146Z monthly 0.5 https://novapharmanews.com/apac/news/psg-2026-specialty-drug-benefits-report-cost-management-coverage-strategies 2026-06-03T17:10:52.808Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-apptec-q1-2026-revenue-growth-backlog-results 2026-06-03T16:10:10.976Z monthly 0.5 https://novapharmanews.com/apac/news/img-pharma-acquires-matsumoto-pharmaceutical-japan-expansion 2026-06-03T11:52:23.817Z monthly 0.5 https://novapharmanews.com/apac/news/aquestive-therapeutics-anaphylm-class-action-lawsuit-approval-timeline 2026-06-03T06:27:49.087Z monthly 0.5 https://novapharmanews.com/apac/news/biomarin-completes-amicus-therapeutics-acquisition-galafold-pompe-therapies 2026-06-03T17:02:24.261Z monthly 0.5 https://novapharmanews.com/eu/news/elanco-negasunt-tanidil-emergency-authorization-screwworm-livestock 2026-06-03T08:03:33.220Z monthly 0.5 https://novapharmanews.com/eu/news/opella-essentiale-excel-trial-fatty-liver-disease-masld-results 2026-06-03T15:38:13.520Z monthly 0.5 https://novapharmanews.com/eu/news/advanced-bifurcation-systems-acquires-svelte-medical-coronary-stent-deal 2026-06-03T13:56:19.950Z monthly 0.5 https://novapharmanews.com/eu/news/zentiva-appeals-eu-court-urban-wastewater-directive-generic-medicines 2026-06-03T05:30:36.291Z monthly 0.5 https://novapharmanews.com/eu/news/ab-science-loan-repayment-deferral-agreement-2026 2026-06-03T10:23:06.153Z monthly 0.5 https://novapharmanews.com/eu/news/mundipharma-rezzayo-rezafungin-phase-iii-respect-trial-results-fungal-disease-prevention 2026-06-03T15:45:19.518Z monthly 0.5 https://novapharmanews.com/eu/news/crinetics-palsonify-paltusotine-eu-approval-acromegaly-treatment 2026-06-03T05:12:29.356Z monthly 0.5 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0801-phase-2-aplastic-anemia-trial 2026-06-03T12:24:12.881Z monthly 0.5 https://novapharmanews.com/us/news/astrazeneca-saphnelo-autoinjector-fda-approved-lupus-self-administration 2026-06-03T13:40:39.577Z monthly 0.5 https://novapharmanews.com/us/news/dmx-200-action3-trial-statistical-power-blinded-review 2026-06-03T11:52:32.615Z monthly 0.5 https://novapharmanews.com/us/news/concept-medical-sirona-trial-3-year-data-charing-cross-2026 2026-06-03T11:52:27.298Z monthly 0.5 https://novapharmanews.com/us/news/intellia-lonvo-z-fda-submission-crispr-hereditary-angioedema 2026-06-03T15:35:14.640Z monthly 0.5 https://novapharmanews.com/us/news/cordis-selution-slr-drug-eluting-balloon-japan-launch-2026 2026-06-03T11:52:27.304Z monthly 0.5 https://novapharmanews.com/us/news/tovecimig-biliary-tract-cancer-trial-results-companion-002 2026-06-03T15:42:06.990Z monthly 0.5 https://novapharmanews.com/us/news/intellia-lonvoguran-ziclumeran-phase-3-hereditary-angioedema-gene-editing 2026-06-03T18:08:52.262Z monthly 0.5 https://novapharmanews.com/us/news/sagimet-biosciences-denifanstat-phase-3-acne-trial-2026 2026-06-03T15:16:59.532Z monthly 0.5 https://novapharmanews.com/us/news/apollomics-vebreltinib-phase-2-3-ind-submission-nsclc-treatment 2026-06-03T12:36:17.241Z monthly 0.5 https://novapharmanews.com/us/news/aclaris-therapeutics-ati-052-phase-1a-results-ati-2138-update-april-2026 2026-06-03T17:28:57.535Z monthly 0.5 https://novapharmanews.com/us/news/ose-immunotherapeutics-pegrizeprument-vel-101-fda-orphan-drug-designation-heart-transplant 2026-06-03T13:32:13.739Z monthly 0.5 https://novapharmanews.com/us/news/jazz-pharmaceuticals-ziihera-fda-priority-review-her2-cancer 2026-06-03T13:28:07.771Z monthly 0.5 https://novapharmanews.com/us/news/nccn-adds-nuvation-bio-taletrectinib-ibtrozi-cancer-guidelines-ros1-nsclc-brain-metastases 2026-06-03T11:52:39.170Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-imaavy-nipocalimab-warm-autoimmune-hemolytic-anemia 2026-06-03T13:22:06.470Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-caplyta-lumateperone-snda-schizophrenia-relapse-prevention 2026-06-03T13:35:35.965Z monthly 0.5 https://novapharmanews.com/us/news/apotex-fda-approval-generic-infuvite-pediatric-injection-exclusivity 2026-06-03T11:52:34.991Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-pharma-news-roundup-april-28-2026 2026-06-03T05:13:05.397Z monthly 0.5 https://novapharmanews.com/us/news/4th-annual-cog-2026-no-pharma-news 2026-06-03T05:13:07.386Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-day-1-roundup 2026-06-03T05:13:09.396Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-patient-centric-trials-workforce 2026-06-03T11:52:37.856Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-regulatory-updates-day-1 2026-06-03T05:13:13.399Z monthly 0.5 https://novapharmanews.com/us/news/testosterone-therapy-fda-update-regulatory-advances 2026-06-03T11:52:45.242Z monthly 0.5 https://novapharmanews.com/us/news/glp-1-eating-disorder-risk-true-facts 2026-06-03T11:52:35.368Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-ai-pathology-oncolytic-virus 2026-06-03T11:52:41.899Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-phillips-medisize-sensing 2026-06-03T05:13:21.490Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-ai-patient-centricity 2026-06-03T05:13:23.423Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-biopharma-medtech-highlights 2026-06-03T12:53:08.055Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-funding-dealmaking-highlights 2026-06-03T05:13:27.437Z monthly 0.5 https://novapharmanews.com/eu/news/asco-2026-olverembatinib-gastric-cancer-trials 2026-06-03T17:57:16.013Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-sustainability-2026-packaging-preview 2026-06-03T11:52:27.216Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-day-1-regulatory-updates 2026-06-03T09:41:57.386Z monthly 0.5 https://novapharmanews.com/apac/news/eyebright-medical-2025-annual-report-sustainability-results 2026-06-03T14:42:17.906Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-japanese-pharmacopoeia-medical-device-standards-regulatory-science 2026-06-03T11:52:23.658Z monthly 0.5 https://novapharmanews.com/eu/news/boston-scientific-securities-class-action-lawsuit-may-2026 2026-06-03T11:52:33.628Z monthly 0.5 https://novapharmanews.com/eu/news/brii-bio-elebsiran-hepatitis-b-control-apasl-2026-analysis 2026-06-03T11:52:32.127Z monthly 0.5 https://novapharmanews.com/us/news/ascletis-asc30-oral-glp-1-diabetes-phase-2-trial-enrollment-complete 2026-06-03T11:52:35.395Z monthly 0.5 https://novapharmanews.com/us/news/ascletis-asc30-phase-ii-enrollment-complete-oral-glp1-diabetes 2026-06-03T11:52:11.316Z monthly 0.5 https://novapharmanews.com/us/news/sun-pharma-acquires-organon-11-75-billion-merger-2026 2026-06-03T17:39:29.176Z monthly 0.5 https://novapharmanews.com/us/news/boston-scientific-farapulse-watchman-heart-rhythm-2026-data 2026-06-03T14:06:24.772Z monthly 0.5 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-male-pattern-hair-loss 2026-06-03T11:52:28.111Z monthly 0.5 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-conference-call 2026-06-03T11:52:32.644Z monthly 0.5 https://novapharmanews.com/us/news/adagio-medical-vclas-ventricular-ablation-system-pivotal-trial-results 2026-06-03T11:52:27.338Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-opens 2026-06-03T05:13:57.460Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-daily-roundup 2026-06-03T11:52:37.785Z monthly 0.5 https://novapharmanews.com/apac/news/pmc-organometallix-price-increase-all-products-may-2026 2026-06-03T06:00:39.966Z monthly 0.5 https://novapharmanews.com/apac/news/tga-personalised-medical-device-regulations-guidance-2024 2026-06-03T11:52:23.226Z monthly 0.5 https://novapharmanews.com/us/news/atara-biotherapeutics-securities-class-action-lawsuit-may-2026-deadline 2026-06-03T11:52:32.453Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-class-action-lawsuit-fda-application 2026-06-03T11:52:32.464Z monthly 0.5 https://novapharmanews.com/us/news/pulse-biosciences-npulse-cardiac-catheter-heart-rhythm-2026-trial-data 2026-06-03T11:57:33.784Z monthly 0.5 https://novapharmanews.com/us/news/abbott-tactiflex-duo-ablation-catheter-afib-results-hrs-2026 2026-06-03T11:52:46.865Z monthly 0.5 https://novapharmanews.com/us/news/medtronic-affera-sphere-9-catheter-fda-breakthrough-device-designation-ventricular-tachycardia 2026-06-03T11:52:46.866Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-rexatilux-ranibizumab-eye-treatment 2026-06-03T05:14:15.480Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-redemplo-plozasiran-european-approval 2026-06-03T07:40:48.294Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-viatris-palbociclib-generic-cancer-treatment 2026-06-03T05:14:19.470Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-itvisma-onasemnogene-abeparvovec-sma-gene-therapy 2026-06-03T11:52:29.909Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-cenrifki-tolebrutinib-multiple-sclerosis 2026-06-03T11:52:29.938Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-first-rna-veterinary-vaccine-nobivac-nxt-cats 2026-06-03T15:00:16.937Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-plozasiran-redemplo-familial-chylomicronaemia-syndrome-fcs 2026-06-03T06:32:16.124Z monthly 0.5 https://novapharmanews.com/eu/news/ema-chmp-recommends-tolebrutinib-cenrifki-five-medicines-approval-april-2026 2026-06-03T16:18:10.774Z monthly 0.5 https://novapharmanews.com/us/news/fda-gdufa-generic-drug-user-fee-amendments-2024-updates 2026-06-03T11:52:47.037Z monthly 0.5 https://novapharmanews.com/us/news/fda-omufa-user-fee-program-otc-monograph-drugs 2026-06-03T13:56:41.581Z monthly 0.5 https://novapharmanews.com/us/news/fda-gdufa-iv-reauthorization-2028-2032-generic-drug-user-fees 2026-06-03T11:52:47.040Z monthly 0.5 https://novapharmanews.com/us/news/fda-testosterone-therapy-low-libido-hypogonadism-2024 2026-06-03T14:20:17.776Z monthly 0.5 https://novapharmanews.com/us/news/fda-reduces-animal-testing-drug-development-alternatives-2024 2026-06-03T15:28:59.237Z monthly 0.5 https://novapharmanews.com/us/news/cms-fda-rapid-coverage-pathway-breakthrough-medical-devices-medicare 2026-06-03T11:52:19.075Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-otarmeni-first-gene-therapy-genetic-hearing-loss 2026-06-03T07:22:00.501Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerates-mental-health-treatment-access-executive-order 2026-06-03T11:52:35.339Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-day-1-roundup 2026-06-03T11:52:37.794Z monthly 0.5 https://novapharmanews.com/us/news/scope-x-2026-clinical-ops-data-ai-boston 2026-06-03T11:52:24.525Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-clinical-trial-innovation 2026-06-03T11:52:39.514Z monthly 0.5 https://novapharmanews.com/apac/news/sunnybrook-41-million-investment-clinical-trials-canada 2026-06-03T05:14:53.526Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-chengdu-microbial-manufacturing-completion-2026 2026-06-03T17:40:30.215Z monthly 0.5 https://novapharmanews.com/apac/news/quasar-medical-thailand-manufacturing-facility-medtech-expansion 2026-06-03T11:52:17.571Z monthly 0.5 https://novapharmanews.com/apac/news/daewoong-nabota-master-class-prabotulinumtoxina-safety-2026 2026-06-03T11:52:23.461Z monthly 0.5 https://novapharmanews.com/apac/news/amcor-35m-healthcare-packaging-facility-malaysia-medical-supply-chain 2026-06-03T17:40:25.897Z monthly 0.5 https://novapharmanews.com/apac/news/transcarent-smithrx-partnership-pharmacy-benefits-platform 2026-06-03T12:59:14.187Z monthly 0.5 https://novapharmanews.com/apac/news/hanchorbio-bloomberg-partnership-drug-development-intelligence 2026-06-03T07:49:07.022Z monthly 0.5 https://novapharmanews.com/eu/news/aetna-prior-authorization-reform-88-percent-standardized-2026 2026-06-03T10:14:22.029Z monthly 0.5 https://novapharmanews.com/eu/news/guerbet-lipiodol-ultra-fluid-eu-approval-vascular-embolization 2026-06-03T05:15:09.545Z monthly 0.5 https://novapharmanews.com/eu/news/rna-therapy-clinical-trials-market-3-4-billion-2035-forecast 2026-06-03T05:15:11.553Z monthly 0.5 https://novapharmanews.com/eu/news/oncotelic-therapeutics-partnership-strategy-update-2026 2026-06-03T09:07:54.642Z monthly 0.5 https://novapharmanews.com/eu/news/clinuvel-scenesse-phase-iii-vitiligo-trial-ema-approval-2026 2026-06-03T05:15:15.540Z monthly 0.5 https://novapharmanews.com/us/news/frankfurt-court-upholds-besremi-arbitral-award-aop-health-pharmaessentia 2026-06-03T12:08:38.963Z monthly 0.5 https://novapharmanews.com/us/news/novartis-coartem-baby-who-prequalification-malaria-treatment-newborns 2026-06-03T12:46:11.222Z monthly 0.5 https://novapharmanews.com/us/news/miracell-smart-m-cell-alzheimers-stem-cell-therapy-results 2026-06-03T11:52:45.937Z monthly 0.5 https://novapharmanews.com/us/news/berlin-heals-positive-cmic-iii-heart-failure-device-results 2026-06-03T12:29:32.739Z monthly 0.5 https://novapharmanews.com/us/news/citius-pharmaceuticals-5-million-direct-offering-stock-nasdaq 2026-06-03T12:11:47.698Z monthly 0.5 https://novapharmanews.com/us/news/haemonetics-vascade-mvp-xl-safety-efficacy-study-large-bore-venous-closure 2026-06-03T14:29:46.045Z monthly 0.5 https://novapharmanews.com/us/news/briohealth-solutions-fda-approval-pediatric-briovad-heart-device-trial 2026-06-03T05:15:29.564Z monthly 0.5 https://novapharmanews.com/us/news/cgbio-fda-clearance-easymade-ti-titanium-implant 2026-06-03T11:52:44.211Z monthly 0.5 https://novapharmanews.com/us/news/cerapedics-vizient-supplier-agreement-pearlmatrix-p15-bone-graft 2026-06-03T10:06:06.663Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-day-1 2026-06-03T11:52:37.795Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-daily-roundup 2026-06-03T11:52:37.797Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-trends 2026-06-03T11:52:37.797Z monthly 0.5 https://novapharmanews.com/apac/news/catalym-visugromab-phase-2-3-trial-cancer-cachexia-first-patient-dosed 2026-06-03T08:18:57.544Z monthly 0.5 https://novapharmanews.com/apac/news/spinogenix-spg601-clarity-trial-fragile-x-syndrome-phase-2b-3 2026-06-03T17:40:28.419Z monthly 0.5 https://novapharmanews.com/apac/news/tga-biologicals-regulatory-framework-advanced-therapies-australia 2026-06-03T18:01:47.737Z monthly 0.5 https://novapharmanews.com/eu/news/renovorx-tamp-therapy-asco-2026-tiger-pac-trial-data 2026-06-03T05:15:47.574Z monthly 0.5 https://novapharmanews.com/eu/news/genomics-services-market-24-billion-2033-precision-medicine 2026-06-03T05:15:49.569Z monthly 0.5 https://novapharmanews.com/eu/news/accenture-invests-iridius-ai-compliance-life-sciences 2026-06-03T05:15:51.575Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-q1-2026-sales-growth-momentum 2026-06-03T05:15:53.574Z monthly 0.5 https://novapharmanews.com/eu/news/cumberland-pharmaceuticals-apotex-strategic-integration-partnership 2026-06-03T05:15:55.572Z monthly 0.5 https://novapharmanews.com/us/news/cortec-brain-interchange-bci-fda-tap-program-stroke-rehabilitation 2026-06-03T11:52:36.481Z monthly 0.5 https://novapharmanews.com/us/news/tivic-health-rebrands-valion-bio-entolimod-acute-radiation-syndrome-fda-fast-track 2026-06-03T11:52:47.775Z monthly 0.5 https://novapharmanews.com/us/news/edwards-lifesciences-q1-2026-results-tmtt-sales-guidance-raise 2026-06-03T11:52:46.909Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-class-action-lawsuit-anktiva 2026-06-03T14:49:38.717Z monthly 0.5 https://novapharmanews.com/us/news/transmedics-chops-organ-preservation-system-ishlt-2026 2026-06-03T05:16:05.589Z monthly 0.5 https://novapharmanews.com/us/news/abbvie-fda-complete-response-letter-trenibotulinumtoxine-trenibote-manufacturing 2026-06-03T11:52:42.950Z monthly 0.5 https://novapharmanews.com/us/news/alpha-tau-fda-approval-alpha-dart-pancreatic-cancer-trial-expansion 2026-06-03T12:37:57.404Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-regeneron-otarmeni-gene-therapy-genetic-hearing-loss 2026-06-03T05:16:11.605Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-parexel-hiring 2026-06-03T18:07:45.785Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day1-roundup 2026-06-03T05:16:15.603Z monthly 0.5 https://novapharmanews.com/us/news/generic-drug-forum-2026-highlights 2026-06-03T16:58:11.437Z monthly 0.5 https://novapharmanews.com/eu/news/tilray-brands-us-medical-cannabis-expansion-rescheduling-2026 2026-06-03T11:52:28.763Z monthly 0.5 https://novapharmanews.com/us/news/capricor-therapeutics-hope-3-phase-3-deramiocel-duchenne-muscular-dystrophy-aan-2026 2026-06-03T11:52:42.895Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-event-pharma-ai-future 2026-06-03T11:52:23.806Z monthly 0.5 https://novapharmanews.com/apac/news/samsung-bioepis-sbe303-phase-1-trial-sandoz-partnership-2026 2026-06-03T11:52:23.109Z monthly 0.5 https://novapharmanews.com/apac/news/fosun-health-wins-awards-globalhealth-asia-pacific-forum-2026 2026-06-03T05:16:37.614Z monthly 0.5 https://novapharmanews.com/apac/news/minjuvi-tafasitamab-approved-australia-follicular-lymphoma 2026-06-03T05:16:39.632Z monthly 0.5 https://novapharmanews.com/eu/news/ccbd-car-t-cell-therapy-maryland-community-oncology 2026-06-03T05:16:41.648Z monthly 0.5 https://novapharmanews.com/eu/news/samacare-prior-authorization-benchmarks-medical-benefit-drugs 2026-06-03T05:16:43.627Z monthly 0.5 https://novapharmanews.com/eu/news/repertoire-immune-medicines-rptr-1-201-phase-1-2-trial-advanced-solid-tumors 2026-06-03T11:52:32.127Z monthly 0.5 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-first-patient 2026-06-03T05:16:47.653Z monthly 0.5 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-europe 2026-06-03T05:16:49.633Z monthly 0.5 https://novapharmanews.com/eu/news/blinatumomab-pediatric-leukemia-safety-study-final-stage 2026-06-03T05:16:51.645Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-third-party-logistics-market-growth-502-billion-2034 2026-06-03T05:16:53.718Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-intermediates-market-57-billion-2035-generic-drugs 2026-06-03T05:16:55.636Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-pediatric-chronic-spontaneous-urticaria-sanofi-regeneron 2026-06-03T05:16:57.642Z monthly 0.5 https://novapharmanews.com/us/news/ose-immunotherapeutics-tedopi-ovarian-cancer-asco-2026-presentation 2026-06-03T11:52:41.896Z monthly 0.5 https://novapharmanews.com/us/news/nectero-therapeutics-east-system-two-year-safety-data-abdominal-aortic-aneurysm 2026-06-03T11:52:45.870Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-oral-semaglutide-children-type-2-diabetes-pioneer-teens-trial 2026-06-03T11:52:35.395Z monthly 0.5 https://novapharmanews.com/us/news/neurosterix-ntx-253-schizophrenia-phase-1-trial-q2-2026 2026-06-03T12:01:41.763Z monthly 0.5 https://novapharmanews.com/us/news/greenwich-lifesciences-glsi-100-asco-2026-breast-cancer-immunotherapy 2026-06-03T15:57:11.147Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-nectin-4-adc-phase-iii-triple-negative-breast-cancer 2026-06-03T11:52:46.329Z monthly 0.5 https://novapharmanews.com/us/news/clearpoint-neuro-fda-clearance-velocity-alpha-surgical-drill-system 2026-06-03T11:52:44.223Z monthly 0.5 https://novapharmanews.com/us/news/vistagen-refisolone-fda-approval-menopause-hot-flashes-phase-2-trial 2026-06-03T11:52:47.922Z monthly 0.5 https://novapharmanews.com/us/news/avai-bio-fda-cellular-rejuvenation-trial-anti-aging-market-120-billion 2026-06-03T11:52:45.465Z monthly 0.5 https://novapharmanews.com/us/news/cipla-fda-approval-first-generic-ventolin-hfa-albuterol-sulfate 2026-06-03T11:52:47.122Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-chronic-spontaneous-urticaria-children-sanofi 2026-06-03T05:17:19.713Z monthly 0.5 https://novapharmanews.com/us/news/oncology-data-trends-2026-preview 2026-06-03T11:56:00.587Z monthly 0.5 https://novapharmanews.com/us/news/redi-2026-fda-regulatory-strategies-conference-preview 2026-06-03T17:40:23.833Z monthly 0.5 https://novapharmanews.com/us/news/bionj-biopartnering-conference-2026-preview 2026-06-03T15:37:56.647Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-2026-boston-preview 2026-06-03T08:45:05.405Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-day-1-eu-takeaways 2026-06-03T05:17:29.768Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-ai-biotech-preview 2026-06-03T05:17:31.750Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-roundup 2026-06-03T05:17:33.730Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-cro-trends-outsourcing 2026-06-03T05:17:35.753Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-biotech-day-1-roundup 2026-06-03T05:17:37.739Z monthly 0.5 https://novapharmanews.com/apac/news/calluna-pharma-cal101-phase-2-enrollment-ipf-treatment 2026-06-03T11:52:22.292Z monthly 0.5 https://novapharmanews.com/apac/news/anixa-biosciences-lira-cel-car-t-ovarian-cancer-survival-data 2026-06-03T11:52:23.290Z monthly 0.5 https://novapharmanews.com/apac/news/hengrui-pharma-q1-2026-anti-pd-l1-tgf-beta-fusion-protein-approved-china 2026-06-03T10:33:21.940Z monthly 0.5 https://novapharmanews.com/apac/news/sonorous-neurovascular-fda-clearance-boscath-catheter-2026 2026-06-03T05:17:45.765Z monthly 0.5 https://novapharmanews.com/apac/news/alphamab-oncology-jskn016-trop2-her3-bispecific-adc-her2-negative-breast-cancer-asco-2026 2026-06-03T12:49:55.241Z monthly 0.5 https://novapharmanews.com/apac/news/rfid-technology-pharmaceutical-supply-chain-15-billion-2032 2026-06-03T05:17:49.757Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-south-korea-gmp-certification-bispecific-antibody-manufacturing 2026-06-03T11:52:17.606Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-therapeutic-sunscreen-regulatory-framework-2024 2026-06-03T05:17:53.774Z monthly 0.5 https://novapharmanews.com/eu/news/belite-bio-tinlarebant-nda-submission-stargardt-disease-phase-3-dragon-trial 2026-06-03T16:30:18.937Z monthly 0.5 https://novapharmanews.com/eu/news/abivax-obefazimod-phase-3-data-digestive-disease-week-2026 2026-06-03T12:01:50.696Z monthly 0.5 https://novapharmanews.com/eu/news/pet-service-holding-2025-annual-results-veterinary-regulatory-changes 2026-06-03T05:17:59.751Z monthly 0.5 https://novapharmanews.com/eu/news/femasys-femaseed-complete-fertility-solution-obgyn-acog-2026 2026-06-03T11:52:33.632Z monthly 0.5 https://novapharmanews.com/eu/news/mauna-kea-technologies-ce-mark-mdr-approval-european-expansion 2026-06-03T11:52:33.637Z monthly 0.5 https://novapharmanews.com/eu/news/pembrolizumab-lenvatinib-clear-cell-cancer-trial-results 2026-06-03T05:40:07.382Z monthly 0.5 https://novapharmanews.com/eu/news/roche-gazyva-fda-acceptance-lupus-treatment-phase-iii-allegory 2026-06-03T05:18:07.757Z monthly 0.5 https://novapharmanews.com/eu/news/dupixent-first-biologic-approved-chronic-spontaneous-urticaria-children 2026-06-03T07:16:44.776Z monthly 0.5 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-eu-approval-pediatric-brain-cancer-braf 2026-06-03T05:18:11.760Z monthly 0.5 https://novapharmanews.com/us/news/alterity-ath434-multiple-system-atrophy-phase-2-results 2026-06-03T11:52:42.903Z monthly 0.5 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-manufacturing-milestone-2026 2026-06-03T11:52:18.531Z monthly 0.5 https://novapharmanews.com/us/news/phanes-therapeutics-spevatamig-phase-2-results-pancreatic-cancer-asco-2026 2026-06-03T09:06:14.155Z monthly 0.5 https://novapharmanews.com/us/news/netris-pharma-np137-pancreatic-cancer-phase-1b-nature-results 2026-06-03T05:18:26.932Z monthly 0.5 https://novapharmanews.com/us/news/neurosterix-ntx-253-phase-1-schizophrenia-trial-q2-2026 2026-06-03T11:52:44.127Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-toripalimab-asco-2026-urothelial-carcinoma 2026-06-03T11:52:18.532Z monthly 0.5 https://novapharmanews.com/us/news/fda-complete-response-letter-atara-biotherapeutics-ebvallo-tabelecleucel-securities-lawsuit 2026-06-03T16:29:11.244Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-securities-lawsuit-fda-warning-letter-cancer-claims 2026-06-03T05:18:27.796Z monthly 0.5 https://novapharmanews.com/us/news/nrx-pharmaceuticals-fda-positive-feedback-preservative-free-ketamine-generic 2026-06-03T11:52:35.349Z monthly 0.5 https://novapharmanews.com/us/news/labcorp-fda-approved-pd-l1-companion-diagnostic-keytruda-ovarian-cancer 2026-06-03T11:52:46.228Z monthly 0.5 https://novapharmanews.com/us/news/veloxis-pegrizeprument-fda-orphan-drug-designation-heart-transplant 2026-06-03T07:28:25.616Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-children-chronic-spontaneous-urticaria-csu 2026-06-03T05:18:35.793Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-daily-roundup 2026-06-03T05:18:37.788Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-highlights 2026-06-03T05:18:39.806Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-news-today-opioid-crisis-drug-pricing-supply-chain 2026-06-03T10:00:11.780Z monthly 0.5 https://novapharmanews.com/eu/news/fda-idvynso-ascentage-asco-2026 2026-06-03T11:52:36.673Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-oncology-highlights 2026-06-03T05:18:45.796Z monthly 0.5 https://novapharmanews.com/apac/news/kelun-biotech-sacituzumab-tirumotecan-asco-2026-presentations 2026-06-03T14:18:30.970Z monthly 0.5 https://novapharmanews.com/apac/news/novi-health-glp-1-hybrid-care-model-clinical-real-world-gap 2026-06-03T05:18:50.735Z monthly 0.5 https://novapharmanews.com/apac/news/duchesnay-peripharm-regulatory-reform-womens-health-access-canada 2026-06-03T10:26:04.303Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-updates-ivd-regulations-medical-device-manufacturers 2026-06-03T05:18:53.802Z monthly 0.5 https://novapharmanews.com/apac/news/washington-state-life-sciences-industry-growth-2024 2026-06-03T05:18:55.901Z monthly 0.5 https://novapharmanews.com/eu/news/redhill-opaganib-neuroblastoma-triple-negative-breast-cancer-aacr-2026 2026-06-03T05:18:57.873Z monthly 0.5 https://novapharmanews.com/eu/news/redhill-opaganib-neuroblastoma-breast-cancer-aacr-2026 2026-06-03T05:18:59.799Z monthly 0.5 https://novapharmanews.com/eu/news/sab-biotherapeutics-sab-142-c-peptide-preservation-type-1-diabetes-phase-1-trial 2026-06-03T07:00:52.209Z monthly 0.5 https://novapharmanews.com/eu/news/boston-scientific-q1-2026-earnings-clinical-trial-results 2026-06-03T11:52:33.639Z monthly 0.5 https://novapharmanews.com/eu/news/cervomed-neflamapimod-brain-volume-increase-dementia-lewy-bodies-aan-2026 2026-06-03T11:52:29.929Z monthly 0.5 https://novapharmanews.com/eu/news/cervomed-neflamapimod-dementia-lewy-bodies-aan-2026-results 2026-06-03T05:19:07.808Z monthly 0.5 https://novapharmanews.com/eu/news/celerion-thl-partners-majority-investment-clinical-research 2026-06-03T09:53:55.872Z monthly 0.5 https://novapharmanews.com/eu/news/veristat-acquires-certara-regulatory-writing-business-european-expansion 2026-06-03T07:38:15.914Z monthly 0.5 https://novapharmanews.com/eu/news/lung-cancer-therapeutics-market-142-billion-precision-medicine-2036 2026-06-03T05:19:13.818Z monthly 0.5 https://novapharmanews.com/eu/news/drug-delivery-devices-market-growth-forecast-2032-biologics 2026-06-03T05:20:21.434Z monthly 0.5 https://novapharmanews.com/eu/news/polycythemia-vera-market-transformation-protagonist-therapeutics-rusfertide-2036 2026-06-03T09:30:44.196Z monthly 0.5 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-first-targeted-therapy-pediatric-brain-tumors-eu-approval 2026-06-03T16:05:54.843Z monthly 0.5 https://novapharmanews.com/eu/news/sanofi-tzield-fda-approval-children-type-1-diabetes-delay 2026-06-03T05:19:21.825Z monthly 0.5 https://novapharmanews.com/us/news/denali-therapeutics-fda-approval-avlayah-tividenofusp-alfa-hunter-syndrome 2026-06-03T15:58:45.513Z monthly 0.5 https://novapharmanews.com/us/news/pfizer-lorbrena-braftovi-asco-2026-cancer-trials 2026-06-03T17:49:37.825Z monthly 0.5 https://novapharmanews.com/us/news/capricor-deramiocel-phase-3-hope-3-duchenne-muscular-dystrophy-aan-2026 2026-06-03T11:52:42.909Z monthly 0.5 https://novapharmanews.com/us/news/boston-scientific-q1-2026-earnings-results-revenue-growth 2026-06-03T17:18:04.792Z monthly 0.5 https://novapharmanews.com/us/news/ractigen-rag-17-als-phase-1-trial-results-2026 2026-06-03T13:12:45.976Z monthly 0.5 https://novapharmanews.com/us/news/avacta-ava6103-cancer-drug-aacr-2026-data-enhertu-comparison 2026-06-03T11:52:47.054Z monthly 0.5 https://novapharmanews.com/us/news/innovent-ibi363-clinical-data-asco-2026 2026-06-03T12:06:12.249Z monthly 0.5 https://novapharmanews.com/us/news/fda-extends-sanofi-sarclisa-subcutaneous-review-multiple-myeloma 2026-06-03T14:19:13.009Z monthly 0.5 https://novapharmanews.com/us/news/nrx-pharmaceuticals-fda-feedback-preservative-free-ketamine-generic 2026-06-03T11:52:35.353Z monthly 0.5 https://novapharmanews.com/us/news/lupin-launches-generic-dapagliflozin-metformin-xr-tablets-us-xigduo-alternative 2026-06-03T14:45:12.481Z monthly 0.5 https://novapharmanews.com/us/news/sanofi-tzield-fda-approval-children-type-1-diabetes-delay 2026-06-03T08:55:03.338Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-sanofi-tzield-children-type-1-diabetes-delay 2026-06-03T11:52:36.056Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-daily-roundup 2026-06-03T14:29:54.213Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-day-1-roundup 2026-06-03T05:19:49.850Z monthly 0.5 https://novapharmanews.com/us/news/generic-drug-forum-us-market-access 2026-06-03T11:52:43.803Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-biotech-innovations-day-1 2026-06-03T05:19:53.851Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-daily-oncology-research-roundup 2026-06-03T05:19:55.853Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-news-purdue-sentencing-supply-chain-asco 2026-06-03T05:19:57.870Z monthly 0.5 https://novapharmanews.com/us/news/generic-drugs-forum-2026-fda-event-opens 2026-06-03T06:58:30.996Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-avantor-biolife-aes-highlights 2026-06-03T09:25:19.789Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-oncology-news-day-1 2026-06-03T06:01:58.153Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-oncology-research-highlights-day-1 2026-06-03T05:20:05.869Z monthly 0.5 https://novapharmanews.com/eu/news/slas-europe-2026-lab-automation-screening 2026-06-03T13:22:46.352Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-partnering-eu-2026-biotech-bdl-preview 2026-06-03T11:52:27.537Z monthly 0.5 https://novapharmanews.com/us/news/fda-redi-conference-2026-preview 2026-06-03T11:52:26.887Z monthly 0.5 https://novapharmanews.com/us/news/scopex-2026-causal-ai-ml-clinical-trials-preview 2026-06-03T16:03:05.554Z monthly 0.5 https://novapharmanews.com/us/news/pharma-manufacturing-innovation-us-2026 2026-06-03T11:52:26.999Z monthly 0.5 https://novapharmanews.com/eu/news/eu-pharma-innovation-trends-2026 2026-06-03T17:40:27.449Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-cardiology-heor-preview 2026-06-03T11:52:37.615Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-2026-biotech-preview 2026-06-03T12:30:24.330Z monthly 0.5 https://novapharmanews.com/us/news/bio-it-world-2026-ai-oncology-preview 2026-06-03T11:52:24.030Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-heor-policy-pharma-pricing 2026-06-03T11:52:37.658Z monthly 0.5 https://novapharmanews.com/us/news/2nd-annual-cog-2026-pharma-preview 2026-06-03T05:20:27.903Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-preview 2026-06-03T12:19:12.164Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-calidi-biotherapeutics-redtail-preview 2026-06-03T18:06:41.297Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-trends-2026 2026-06-03T05:20:37.439Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-cell-gene-therapy-manufacturing-dublin 2026-06-03T05:20:35.904Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-preview 2026-06-03T12:29:05.852Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-manufacturing-preview 2026-06-03T11:52:26.677Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-2026-pharma-exec-networking 2026-06-03T05:20:41.981Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-2026-pharma-insights 2026-06-03T11:52:41.733Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-2026-eu-mdr-regulatory-tech 2026-06-03T12:30:53.824Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-clinical-trial-tech 2026-06-03T05:20:49.632Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-preview 2026-06-03T05:20:49.978Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-preview 2026-06-03T12:29:53.962Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-2026-preview 2026-06-03T16:05:31.838Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-2026-biotech-dealmaking 2026-06-03T17:50:47.067Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-summit-2026-preview 2026-06-03T12:29:24.463Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-oncology-asco-aua 2026-06-03T05:21:04.938Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026 2026-06-03T11:52:13.831Z monthly 0.5 https://novapharmanews.com/us/news/4th-annual-cog-preview 2026-06-03T05:21:09.795Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-apac-biotech-preview 2026-06-03T09:18:59.166Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-preview 2026-06-03T17:12:05.944Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-pembrolizumab-bowel-cancer-moderna-melanoma 2026-06-03T05:21:10.135Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-day3-immunotherapy-kras-mrna 2026-06-03T16:17:51.601Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-preview 2026-06-03T11:52:37.824Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-2024-preview 2026-06-03T05:21:16.148Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-2024-preview-eu 2026-06-03T05:21:18.136Z monthly 0.5 https://novapharmanews.com/apac/news/suvoda-agentic-ai-rtsm-clinical-trial-startup-reduction 2026-06-03T05:21:20.155Z monthly 0.5 https://novapharmanews.com/apac/news/dayspring-pharma-cg2001-foam-phase-ii-trial-androgenetic-alopecia-results 2026-06-03T09:06:46.868Z monthly 0.5 https://novapharmanews.com/apac/news/myome-board-appointments-healthcare-leaders-ai-genomics 2026-06-03T05:21:24.152Z monthly 0.5 https://novapharmanews.com/apac/news/synbiotech-l-plantarum-fs4722-hyperuricemia-prevention-preclinical 2026-06-03T05:22:52.427Z monthly 0.5 https://novapharmanews.com/apac/news/nasal-sprays-market-29-billion-2036-allergy-growth 2026-06-03T05:21:28.165Z monthly 0.5 https://novapharmanews.com/apac/news/andelyn-biosciences-encell-gene-therapy-manufacturing-partnership 2026-06-03T17:40:26.843Z monthly 0.5 https://novapharmanews.com/apac/news/turbine-crown-bioscience-ai-organoid-cancer-drug-discovery-partnership 2026-06-03T05:21:32.176Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-medicinal-cannabis-pediatric-access-guidelines-2024 2026-06-03T05:21:34.169Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-unapproved-therapeutic-goods-special-access-scheme-guidance 2026-06-03T17:56:14.994Z monthly 0.5 https://novapharmanews.com/apac/news/ghit-fund-invests-8-5-million-malaria-ntd-drug-development-gsk-eisai 2026-06-03T15:08:15.686Z monthly 0.5 https://novapharmanews.com/apac/news/ghit-fund-8-5-million-malaria-ntd-drug-development-gsk-eisai 2026-06-03T05:21:40.177Z monthly 0.5 https://novapharmanews.com/eu/news/kelun-biotech-sac-tmt-asco-2026-presentations 2026-06-03T05:21:42.183Z monthly 0.5 https://novapharmanews.com/eu/news/prescriberpoint-ai-prior-authorization-platform-clinician-acceptance-rate 2026-06-03T05:21:44.169Z monthly 0.5 https://novapharmanews.com/eu/news/grail-galleri-cancer-detection-asco-2026-results 2026-06-03T16:41:09.778Z monthly 0.5 https://novapharmanews.com/eu/news/eupraxia-pharmaceuticals-positive-resolve-trial-eosinophilic-esophagitis-data 2026-06-03T05:21:54.484Z monthly 0.5 https://novapharmanews.com/eu/news/cellcarta-regask-ai-platform-regulatory-compliance-efficiency 2026-06-03T13:16:36.168Z monthly 0.5 https://novapharmanews.com/eu/news/leerink-partners-medincell-outperform-uzedy-risperidone-lai-fda-approval 2026-06-03T09:30:58.010Z monthly 0.5 https://novapharmanews.com/eu/news/getinge-cardiohelp-ii-ce-mark-intergard-synergy-eu-mdr-approval 2026-06-03T11:52:33.650Z monthly 0.5 https://novapharmanews.com/eu/news/karyopharm-phase-3-sentry-trial-asco-2026-myelofibrosis 2026-06-03T18:05:30.079Z monthly 0.5 https://novapharmanews.com/eu/news/allogene-therapeutics-expands-cemacabtagene-ansegedleucel-alpha3-trial-south-korea-australia 2026-06-03T05:21:58.185Z monthly 0.5 https://novapharmanews.com/eu/news/biocon-health-canada-approval-denosumab-biosimilars-bosaya-vevzuo 2026-06-03T05:22:00.185Z monthly 0.5 https://novapharmanews.com/us/news/francis-medical-vanquish-prostate-ablation-midwest-first-procedure 2026-06-03T11:52:34.066Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-anaphylm-fda-deficiencies-class-action-lawsuit 2026-06-03T18:08:18.686Z monthly 0.5 https://novapharmanews.com/us/news/efemoral-medical-bioresorbable-scaffold-97-percent-patency-peripheral-artery-disease 2026-06-03T16:37:11.570Z monthly 0.5 https://novapharmanews.com/us/news/kyverna-miv-cel-stiff-person-syndrome-trial-results-breakthrough 2026-06-03T05:22:08.185Z monthly 0.5 https://novapharmanews.com/us/news/invera-medical-90-percent-vein-closure-chronic-venous-disease-trial-results 2026-06-03T11:52:46.392Z monthly 0.5 https://novapharmanews.com/us/news/reva-medical-motiv-scaffold-superior-results-critical-limb-ischemia-trial 2026-06-03T11:52:46.408Z monthly 0.5 https://novapharmanews.com/us/news/ractigen-rag-17-als-phase-1-results-neurofilament-reduction 2026-06-03T05:22:19.933Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-nectin-4-adc-bulumtatug-fuvedotin-cervical-cancer-nejm-case-report 2026-06-03T11:52:45.116Z monthly 0.5 https://novapharmanews.com/us/news/outlook-therapeutics-fda-dispute-resolution-lytenava-bevacizumab 2026-06-03T18:02:03.967Z monthly 0.5 https://novapharmanews.com/us/news/follicular-lymphoma-clinical-trials-45-companies-2026 2026-06-03T11:52:42.940Z monthly 0.5 https://novapharmanews.com/us/news/obsidian-therapeutics-obx-115-phase-2-melanoma-asco-2026 2026-06-03T15:53:23.599Z monthly 0.5 https://novapharmanews.com/us/news/icecure-medical-prosense-revenue-increases-30-percent-q1-2026 2026-06-03T11:52:43.055Z monthly 0.5 https://novapharmanews.com/us/news/nuvalent-neladalkib-alkove-1-trial-data-asco-2026-alk-positive-nsclc 2026-06-03T05:22:27.596Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-merck-idvynso-hiv-treatment-doravirine-islatravir 2026-06-03T11:52:47.179Z monthly 0.5 https://novapharmanews.com/apac/news/peptidream-asahi-kasei-ak1940-phase-1-clinical-trial 2026-06-03T17:36:43.095Z monthly 0.5 https://novapharmanews.com/apac/news/rznomics-rz-001-hepatocellular-carcinoma-trial-results-aacr-2026 2026-06-03T11:52:23.291Z monthly 0.5 https://novapharmanews.com/apac/news/biogen-acquires-felzartamab-tj-biopharma-china 2026-06-03T11:52:23.255Z monthly 0.5 https://novapharmanews.com/apac/news/argo-biopharma-bw-40202-phase-ii-trials-sirna-therapy 2026-06-03T14:38:36.959Z monthly 0.5 https://novapharmanews.com/apac/news/mabwell-bioscience-pics-gmp-inspection-denosumab-biosimilars-jordan 2026-06-03T11:52:23.128Z monthly 0.5 https://novapharmanews.com/apac/news/mabwell-t-mab-jordan-gmp-inspection-denosumab-biosimilars-approval 2026-06-03T11:52:23.135Z monthly 0.5 https://novapharmanews.com/apac/news/quality-executive-partners-vienni-virtuosi-india-pharmaceutical-training 2026-06-03T05:22:42.223Z monthly 0.5 https://novapharmanews.com/apac/news/synsmart-amporin-partnership-small-molecule-therapeutics-degenerative-diseases 2026-06-03T11:52:23.464Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-otc-medicine-registration-guidelines-update 2026-06-03T05:22:46.230Z monthly 0.5 https://novapharmanews.com/apac/news/methylphenidate-shortage-update-concerta-ritalin-rubifen-supply-2026 2026-06-03T05:22:48.230Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-approves-peripheral-rotablator-pro-visual-ice-cryoablation-system-japan 2026-06-03T11:52:23.586Z monthly 0.5 https://novapharmanews.com/eu/news/cigna-healthcare-imuldosa-biosimilar-preferred-coverage-accord-biopharma 2026-06-03T05:22:52.250Z monthly 0.5 https://novapharmanews.com/eu/news/briacell-bria-ots-phase-3-breast-cancer-quality-life-aacr-2026 2026-06-03T05:22:54.324Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-isolators-market-782-billion-eu-gmp-annex-1 2026-06-03T11:52:19.038Z monthly 0.5 https://novapharmanews.com/eu/news/mabwell-pics-gmp-compliance-jordan-fda-biopharmaceutical-manufacturing 2026-06-03T11:52:19.042Z monthly 0.5 https://novapharmanews.com/eu/news/implantica-refluxstop-device-safety-study-602-patients-europe 2026-06-03T11:52:33.668Z monthly 0.5 https://novapharmanews.com/eu/news/askbio-ametefgene-parvec-phase-ii-parkinson-gene-therapy 2026-06-03T05:23:02.239Z monthly 0.5 https://novapharmanews.com/us/news/lenz-therapeutics-vizz-presbyopia-uk-mhra-approval-submission 2026-06-03T05:23:04.260Z monthly 0.5 https://novapharmanews.com/us/news/pasithea-pas-004-fda-rare-pediatric-disease-designation-nf1 2026-06-03T05:23:06.266Z monthly 0.5 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-safety-endpoint-alcohol-use-disorder-trial 2026-06-03T11:52:45.736Z monthly 0.5 https://novapharmanews.com/us/news/sapience-therapeutics-st316-phase-2-colorectal-cancer-results 2026-06-03T11:52:18.738Z monthly 0.5 https://novapharmanews.com/us/news/tozorakimab-phase-3-miranda-trial-copd-exacerbations-reduction 2026-06-03T05:23:18.662Z monthly 0.5 https://novapharmanews.com/us/news/abogen-abo2203-mrna-cancer-therapy-b-cell-lymphoma-trial-aacr-2026 2026-06-03T11:52:19.173Z monthly 0.5 https://novapharmanews.com/us/news/verismo-synkir-110-phase-1-trial-results-aacr-2026 2026-06-03T11:52:18.745Z monthly 0.5 https://novapharmanews.com/us/news/inhibrx-ozekibart-inbrx-109-colorectal-cancer-clinical-update-webcast 2026-06-03T11:52:46.215Z monthly 0.5 https://novapharmanews.com/us/news/akeso-cadonilimab-pancreatic-cancer-phase-2-trial-results 2026-06-03T11:52:19.174Z monthly 0.5 https://novapharmanews.com/us/news/debiopharm-lunresertib-fda-fast-track-ovarian-cancer 2026-06-03T12:23:43.599Z monthly 0.5 https://novapharmanews.com/us/news/adcendo-adce-t02-expansion-phase-adce-d01-fda-orphan-drug-designation 2026-06-03T11:52:18.755Z monthly 0.5 https://novapharmanews.com/us/news/fda-accepts-genentech-gazyva-lupus-treatment-application 2026-06-03T05:23:26.266Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-padcev-keytruda-bladder-cancer-astellas 2026-06-03T10:51:19.479Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-dermaclear-severe-acne-2026 2026-06-03T05:23:30.285Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cell-therapy-multiple-sclerosis-2024 2026-06-03T14:42:58.608Z monthly 0.5 https://novapharmanews.com/us/news/fda-biosimilar-substitution-policy-update-2024 2026-06-03T11:52:42.151Z monthly 0.5 https://novapharmanews.com/eu/news/ema-biosimilar-policy-impact-2024 2026-06-03T11:52:44.796Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-paxlovid-covid19-treatment-eua-2024 2026-06-03T05:23:38.298Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-riabni-rituximab-biosimilar-nhl-2024 2026-06-03T11:52:37.079Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-adagrasib-kras-g12c-nsclc-2024 2026-06-03T16:11:17.807Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-apretude-injectable-prep-hiv-2024 2026-06-03T13:52:56.101Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-skin-renew-new-indication-severe-eczema-2024 2026-06-03T10:29:27.895Z monthly 0.5 https://novapharmanews.com/us/news/fda-update-diabetes-therapy-label-warning-2024 2026-06-03T09:28:35.307Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-genopharm-geno-cure-targeted-cancer-2024 2026-06-03T12:14:12.764Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-allerclear-otc-seasonal-allergies-2024 2026-06-03T05:23:52.293Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bact-away-antibiotic-resistant-infections-2024 2026-06-03T05:23:58.067Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-algorithma-algo-1-trd-2024 2026-06-03T17:02:19.103Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-trial-update-semaglutide-obesity-2024 2026-06-03T18:05:37.285Z monthly 0.5 https://novapharmanews.com/apac/news/alamar-biosciences-nasdaq-ipo-precision-proteomics-debut 2026-06-03T05:24:00.315Z monthly 0.5 https://novapharmanews.com/apac/news/act-genomics-101-gene-panel-cancer-testing-upgrade-2026 2026-06-03T05:24:04.116Z monthly 0.5 https://novapharmanews.com/apac/news/qdenga-dengue-vaccine-approved-australia-tga-four-serotypes 2026-06-03T05:24:04.309Z monthly 0.5 https://novapharmanews.com/eu/news/ema-iris-psur-submission-requirements-september-2025 2026-06-03T08:25:28.800Z monthly 0.5 https://novapharmanews.com/us/news/revolution-medicines-zoldonrasib-phase-1-data-kras-g12d-lung-cancer-aacr-2026 2026-06-03T17:43:36.452Z monthly 0.5 https://novapharmanews.com/us/news/epibiologics-epi-326-phase-1-trial-egfr-cancer 2026-06-03T05:24:10.313Z monthly 0.5 https://novapharmanews.com/us/news/sbc-medical-group-secondary-offering-3-1-million-shares 2026-06-03T11:52:46.296Z monthly 0.5 https://novapharmanews.com/us/news/fda-terminates-gas-delivery-engine-ventilator-recall-16650a 2026-06-03T05:24:14.314Z monthly 0.5 https://novapharmanews.com/us/news/philip-morris-iqos-fda-reauthorization-modified-risk-tobacco-product 2026-06-03T17:13:31.904Z monthly 0.5 https://novapharmanews.com/us/news/ascentage-pharma-preclinical-cancer-studies-aacr-2026 2026-06-03T05:24:18.319Z monthly 0.5 https://novapharmanews.com/us/news/whitehawk-therapeutics-hwk-007-adc-data-aacr-2026 2026-06-03T14:06:21.291Z monthly 0.5 https://novapharmanews.com/us/news/pulnovo-medical-100-million-medtronic-investment-pulmonary-hypertension 2026-06-03T11:52:45.896Z monthly 0.5 https://novapharmanews.com/us/news/nuance-pharma-ohtuvayre-enhance-china-phase-3-copd-results-chest-journal 2026-06-03T05:24:24.324Z monthly 0.5 https://novapharmanews.com/us/news/lundbeck-vyepti-migraine-cognitive-symptoms-infuse-study-2026 2026-06-03T11:52:18.751Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-biosimilar-clone-remicade-2026 2026-06-03T13:57:47.649Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-arterioflow-pad-2024 2026-06-03T05:24:30.348Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-v-protect-vaccine-2026 2026-06-03T13:58:04.561Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-inno-med-inhaler-tech-asthma-2024 2026-06-03T05:24:34.351Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-duo-boost-type-2-diabetes-2024 2026-06-03T05:24:36.337Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-rgen-101-raregen-orphan-drug-2024 2026-06-03T09:26:18.434Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-inflammex-ulcerative-colitis-2026 2026-06-03T05:24:40.342Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-synapton-alzheimers-2026 2026-06-03T15:24:06.743Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-generic-epipen-mylan-2024 2026-06-03T05:24:44.345Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-prevnar-20-pediatric-indication-2024 2026-06-03T05:24:46.349Z monthly 0.5 https://novapharmanews.com/apac/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-diseases 2026-06-03T12:53:20.585Z monthly 0.5 https://novapharmanews.com/apac/news/zai-lab-zl-1503-bispecific-antibody-atopic-disease-itch-relief-preclinical-data 2026-06-03T11:52:23.749Z monthly 0.5 https://novapharmanews.com/apac/news/antengene-novel-cancer-programs-aacr-2026-adc-tce-therapies 2026-06-03T05:24:52.358Z monthly 0.5 https://novapharmanews.com/apac/news/antengene-adc-antengager-tce-programs-aacr-2026 2026-06-03T05:24:54.358Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-therapeutic-vaping-pharmacy-access-regulatory-framework 2026-06-03T12:43:46.495Z monthly 0.5 https://novapharmanews.com/apac/news/tga-medical-device-regulations-ai-software-therapeutic-products-australia 2026-06-03T05:24:58.363Z monthly 0.5 https://novapharmanews.com/eu/news/adagene-muzastotug-triple-combination-therapy-hepatocellular-carcinoma-aacr-2026 2026-06-03T05:25:00.387Z monthly 0.5 https://novapharmanews.com/eu/news/hytn-innovations-hard-cannabis-remediation-technology-gmp-processing-germany 2026-06-03T05:25:02.374Z monthly 0.5 https://novapharmanews.com/eu/news/sanofi-nuvaxovid-covid-vaccine-better-tolerability-mnexspike-phase-4-study 2026-06-03T05:25:04.383Z monthly 0.5 https://novapharmanews.com/eu/news/brand-institute-ema-approval-ai-pharmaceutical-branding-brandi-platform 2026-06-03T05:25:06.381Z monthly 0.5 https://novapharmanews.com/eu/news/ema-drug-patent-cliff-2026-european-exclusivities-expire 2026-06-03T16:58:59.937Z monthly 0.5 https://novapharmanews.com/eu/news/ema-chmp-recommends-six-new-medicines-approval-february-2024 2026-06-03T05:25:13.157Z monthly 0.5 https://novapharmanews.com/eu/news/ema-recommends-adstiladrin-gene-therapy-bladder-cancer-march-2026 2026-06-03T07:40:57.413Z monthly 0.5 https://novapharmanews.com/us/news/health-canada-approves-bracco-vueway-gadopiclenol-mri-contrast 2026-06-03T11:52:46.434Z monthly 0.5 https://novapharmanews.com/us/news/salubris-jk06-phase-1-2-cancer-trial-aacr-2024 2026-06-03T11:52:41.895Z monthly 0.5 https://novapharmanews.com/us/news/innate-pharma-iph5201-matisse-phase-2-aacr-2026-plenary-session 2026-06-03T11:52:19.217Z monthly 0.5 https://novapharmanews.com/us/news/accent-therapeutics-atx-295-kif18a-inhibitor-aacr-2026-cancer-data 2026-06-03T11:52:45.124Z monthly 0.5 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-atopic-disease-itch-relief 2026-06-03T11:52:29.549Z monthly 0.5 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-dermatitis-preclinical 2026-06-03T11:52:29.545Z monthly 0.5 https://novapharmanews.com/us/news/fda-reauthorizes-philip-morris-iqos-modified-risk-tobacco-product 2026-06-03T11:52:46.240Z monthly 0.5 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-disease-preclinical-data 2026-06-03T05:25:28.395Z monthly 0.5 https://novapharmanews.com/us/news/olema-oncology-palazestrant-op-3136-preclinical-data-aacr-2026 2026-06-03T16:09:47.782Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-neurona-therapeutics-nrtx-1001-epilepsy-cell-therapy 2026-06-03T10:33:07.974Z monthly 0.5 https://novapharmanews.com/us/news/xodus-medical-fda-clearance-hot-pink-pad-surgical-temperature-management 2026-06-03T05:46:09.332Z monthly 0.5 https://novapharmanews.com/us/news/argenx-vyvgart-myasthenia-gravis-cidp-aan-2026-clinical-data 2026-06-03T05:25:36.399Z monthly 0.5 https://novapharmanews.com/us/news/nuvalent-zidesamtinib-ros1-lung-cancer-aacr-2026 2026-06-03T13:57:31.523Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-verapamil-extended-release-hypertension-2024 2026-06-03T11:52:42.408Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-imgn-901-breakthrough-therapy-aml-2026 2026-06-03T05:25:42.416Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-revitan-gene-therapy-sma-type-3-2026 2026-06-03T05:25:49.747Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mito-x-accelerated-approval-2024 2026-06-03T11:52:36.622Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-xylocor-refractory-angina-2026 2026-06-03T05:46:09.345Z monthly 0.5 https://novapharmanews.com/apac/news/atara-biotherapeutics-class-action-lawsuit-atra-stockholders-losses 2026-06-03T05:25:50.435Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-hanmi-hmpl-523-alzheimer-herbal-medicine 2026-06-03T05:25:52.421Z monthly 0.5 https://novapharmanews.com/eu/news/gene-therapy-market-growth-crispr-aav-technologies-2034 2026-06-03T05:25:54.421Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-cold-chain-logistics-market-growth-2034-biopharmaceuticals-asia-pacific 2026-06-03T17:05:42.706Z monthly 0.5 https://novapharmanews.com/eu/news/aim-immunotech-ampligen-phase-3-pancreatic-cancer-trial-orphan-drug 2026-06-03T05:25:58.504Z monthly 0.5 https://novapharmanews.com/eu/news/ab-science-masitinib-als-phase-3-trial-insurance-25-million 2026-06-03T05:26:00.435Z monthly 0.5 https://novapharmanews.com/eu/news/meiragTx-acquires-botaretigene-sparoparvovec-gene-therapy-xlrp-johnson-johnson 2026-06-03T05:26:02.429Z monthly 0.5 https://novapharmanews.com/eu/news/beamion-zongertinib-fda-approval-her2-mutant-nsclc-lung-1-study 2026-06-03T05:26:04.457Z monthly 0.5 https://novapharmanews.com/eu/news/tri-611-fda-fast-track-alk-positive-nsclc-eisai-taletrectinib 2026-06-03T05:26:06.438Z monthly 0.5 https://novapharmanews.com/us/news/maia-biotechnology-phase-2-nsclc-telomere-treatment-trial-us-site 2026-06-03T05:26:08.433Z monthly 0.5 https://novapharmanews.com/us/news/dr-falk-pharma-renexxion-naronapride-phase-2b-gastroparesis-ddw-2026 2026-06-03T12:21:12.541Z monthly 0.5 https://novapharmanews.com/us/news/lilly-foundayo-orforglipron-achieve-4-trial-results-mortality-reduction 2026-06-03T13:56:41.368Z monthly 0.5 https://novapharmanews.com/us/news/aicuris-pritelivir-fda-priority-review-herpes-treatment 2026-06-03T11:52:45.506Z monthly 0.5 https://novapharmanews.com/us/news/medera-aav-serca2a-fda-fast-track-duchenne-cardiomyopathy 2026-06-03T11:52:45.896Z monthly 0.5 https://novapharmanews.com/us/news/boehringer-ingelheim-zongertinib-her2-mutant-lung-cancer-nejm-study 2026-06-03T16:40:33.684Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mindbalance-digital-therapeutic-2026 2026-06-03T13:30:15.818Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cancervax-adjuvant-melanoma-2026 2026-06-03T11:52:36.852Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-painblock-patch-chronic-pain-2024 2026-06-03T05:26:24.439Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-renalprotect-expanded-use-dkd-2024 2026-06-03T07:53:33.685Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-lungrx-inhaled-therapy-pulmonary-hypertension-2026 2026-06-03T05:59:11.921Z monthly 0.5 https://novapharmanews.com/apac/news/sanyou-ai-stal-2-antibody-discovery-14-days-drug-development 2026-06-03T05:26:30.465Z monthly 0.5 https://novapharmanews.com/apac/news/gene-expression-analysis-market-593-billion-2031-drug-discovery 2026-06-03T11:52:23.298Z monthly 0.5 https://novapharmanews.com/apac/news/perceptive-discovery-mh3d-alpha-sight-radiopharmaceutical-imaging 2026-06-03T05:26:34.460Z monthly 0.5 https://novapharmanews.com/apac/news/pg-health-apac-pharmacist-guidelines-peripheral-neuropathy-management 2026-06-03T05:26:36.455Z monthly 0.5 https://novapharmanews.com/apac/news/tga-assessed-listed-medicines-framework-update-australia 2026-06-03T05:26:38.470Z monthly 0.5 https://novapharmanews.com/apac/news/corcept-therapeutics-relacorilant-fda-rejection-investor-lawsuit-2025 2026-06-03T11:05:24.779Z monthly 0.5 https://novapharmanews.com/apac/news/florida-cancer-specialists-medically-integrated-oncology-care-2024 2026-06-03T05:26:42.464Z monthly 0.5 https://novapharmanews.com/eu/news/traws-pharma-tivoxavir-marboxil-influenza-trial-ratutrelvir-covid-results-2025 2026-06-03T05:26:44.477Z monthly 0.5 https://novapharmanews.com/eu/news/tme-pharma-nox-a12-triple-therapy-brain-cancer-gloria-trial-nature-communications 2026-06-03T05:26:46.481Z monthly 0.5 https://novapharmanews.com/eu/news/additional-risk-minimization-measures-armms-training-course-patient-safety 2026-06-03T05:26:48.475Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-logistics-market-growth-159-billion-2030-biopharmaceutical-cold-chain 2026-06-03T05:26:59.766Z monthly 0.5 https://novapharmanews.com/eu/news/medical-device-software-compliance-training-eu-mdr-ivdr-fda-june-2026 2026-06-03T05:26:52.479Z monthly 0.5 https://novapharmanews.com/eu/news/onward-medical-40-million-capital-increase-eqt-life-sciences 2026-06-03T05:26:54.485Z monthly 0.5 https://novapharmanews.com/eu/news/sahpra-african-medicines-agency-regulatory-harmonization-course-may-2026 2026-06-03T05:26:56.484Z monthly 0.5 https://novapharmanews.com/eu/news/bavarian-nordic-vimkunya-chikungunya-vaccine-swiss-approval-swissmedic 2026-06-03T05:26:58.487Z monthly 0.5 https://novapharmanews.com/eu/news/seragon-srn-901-longevity-drug-lifespan-extension-preclinical-study 2026-06-03T14:29:52.891Z monthly 0.5 https://novapharmanews.com/us/news/fda-food-additive-contact-substance-regulatory-updates-2026 2026-06-03T11:52:46.973Z monthly 0.5 https://novapharmanews.com/us/news/recognition-health-alzheimers-blood-test-clinical-trial-2026 2026-06-03T11:52:46.443Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-maiweijian-denosumab-nmpa-acceptance-cancer-bone-metastases 2026-06-03T11:52:45.873Z monthly 0.5 https://novapharmanews.com/us/news/sedogen-diazoxide-patent-prader-willi-syndrome-behavioral-symptoms 2026-06-03T05:27:08.488Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-lilrb4-cd3-bispecific-antibody-6mw5311-nmpa-ind-approval-leukemia 2026-06-03T11:52:45.382Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-maiweijian-denosumab-nmpa-acceptance-cancer-bone-treatment 2026-06-03T11:52:46.314Z monthly 0.5 https://novapharmanews.com/us/news/thinktrends-ai-federal-health-agency-adverse-event-monitoring-system 2026-06-03T11:52:47.716Z monthly 0.5 https://novapharmanews.com/us/news/fullscript-journeys-digital-health-platform-launch-2024 2026-06-03T11:52:11.868Z monthly 0.5 https://novapharmanews.com/us/news/nexalin-technology-fda-alzheimers-strategy-meetings-china-us 2026-06-03T11:52:45.552Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-class-action-lawsuit-ankt 2026-06-03T12:23:30.189Z monthly 0.5 https://novapharmanews.com/us/news/fda-warning-letters-pharmaceutical-compliance-drug-safety-2024 2026-06-03T16:07:16.186Z monthly 0.5 https://novapharmanews.com/us/news/gsk-depemokimab-european-chinese-approval-ultra-long-acting-biologic 2026-06-03T16:47:02.812Z monthly 0.5 https://novapharmanews.com/us/news/elion-therapeutics-turletricin-phase-2-trial-invasive-mold-infections 2026-06-03T14:06:05.441Z monthly 0.5 https://novapharmanews.com/us/news/glaukos-epioxa-permanent-j-code-j2789-cms-approval 2026-06-03T17:38:15.516Z monthly 0.5 https://novapharmanews.com/us/news/nkarta-fda-approval-outpatient-nkx019-dosing-autoimmune-disease 2026-06-03T11:52:45.491Z monthly 0.5 https://novapharmanews.com/apac/news/phantom-neuro-phantom-x-first-human-trial-approval-australia 2026-06-03T11:52:34.711Z monthly 0.5 https://novapharmanews.com/eu/news/boehringer-ingelheim-zai-lab-dll3-targeting-combination-therapy-small-cell-lung-cancer-trial 2026-06-03T05:27:34.517Z monthly 0.5 https://novapharmanews.com/eu/news/imvt-1402-myasthenia-gravis-treatment-pipeline-2026 2026-06-03T18:15:35.018Z monthly 0.5 https://novapharmanews.com/us/news/dogwood-therapeutics-sp16-fda-ind-approval-chemotherapy-pain 2026-06-03T05:27:38.522Z monthly 0.5 https://novapharmanews.com/us/news/pds-biotech-pds01adc-78-percent-response-rate-colorectal-cancer-phase-2 2026-06-03T11:52:44.787Z monthly 0.5 https://novapharmanews.com/us/news/neffy-epinephrine-nasal-spray-approved-canada-needle-free-anaphylaxis-treatment 2026-06-03T11:52:46.589Z monthly 0.5 https://novapharmanews.com/us/news/cala-fda-clearance-kiq-plus-wearable-device-essential-tremor-parkinsons 2026-06-03T17:29:54.728Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-rapiblyk-landiolol-pediatric-svt-aop-health 2026-06-03T11:52:46.867Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-gi-innovation-gi-101a-phase-1-data-preview 2026-06-03T16:02:38.077Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-sleepwell-chronic-insomnia-2026 2026-06-03T16:23:40.637Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-nanopharm-metastatic-breast-cancer-2024 2026-06-03T11:52:32.832Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-fluguard-novel-influenza-vaccine-2026 2026-06-03T05:27:54.539Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cardiodetect-ai-diagnostic-arrhythmia-2026 2026-06-03T15:08:48.639Z monthly 0.5 https://novapharmanews.com/apac/news/phrontline-biopharma-tj106-her2-adc-preclinical-data-aacr-2026 2026-06-03T09:22:52.222Z monthly 0.5 https://novapharmanews.com/apac/news/xellsmart-xs411-parkinsons-cell-therapy-phase-ii-trial-2026 2026-06-03T10:08:13.958Z monthly 0.5 https://novapharmanews.com/apac/news/peer-ai-regulatory-platform-predictive-intelligence-life-sciences 2026-06-03T18:08:41.161Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-iso-13485-certification-drug-device-combination-products 2026-06-03T11:52:17.647Z monthly 0.5 https://novapharmanews.com/apac/news/atelerix-jh-health-partnership-cell-preservation-middle-east 2026-06-03T05:28:06.549Z monthly 0.5 https://novapharmanews.com/apac/news/chitosan-market-growth-kitozyme-primex-pharmaceutical-biopolymer-2036 2026-06-03T05:28:08.564Z monthly 0.5 https://novapharmanews.com/apac/news/telix-tlx101-tx-phase-3-glioblastoma-trial-first-patient 2026-06-03T05:28:10.557Z monthly 0.5 https://novapharmanews.com/apac/news/nmn-500mg-energy-support-tga-approval-australia 2026-06-03T05:28:12.554Z monthly 0.5 https://novapharmanews.com/eu/news/drug-development-services-market-31-billion-2026-pharma-rd-investments 2026-06-03T05:28:14.564Z monthly 0.5 https://novapharmanews.com/eu/news/medicenna-bizaxofusp-brain-cancer-trials-2026-investor-conference 2026-06-03T18:10:45.656Z monthly 0.5 https://novapharmanews.com/eu/news/vitestro-autonomous-robotic-phlebotomy-device-clinical-trial-results 2026-06-03T05:28:18.572Z monthly 0.5 https://novapharmanews.com/eu/news/grace-therapeutics-gtx-104-phase-3-strive-on-trial-aan-2026 2026-06-03T05:28:20.564Z monthly 0.5 https://novapharmanews.com/eu/news/mena-medical-device-regulatory-training-course-may-2026 2026-06-03T05:28:22.597Z monthly 0.5 https://novapharmanews.com/eu/news/cmo-cdmo-market-growth-biologics-manufacturing-2035 2026-06-03T11:52:19.071Z monthly 0.5 https://novapharmanews.com/eu/news/clinical-trial-monitoring-gcp-compliance-course-2026 2026-06-03T05:28:26.568Z monthly 0.5 https://novapharmanews.com/eu/news/gcp-inspections-training-course-ich-e6-r3-eu-ctr-compliance-july-2026 2026-06-03T05:28:28.569Z monthly 0.5 https://novapharmanews.com/eu/news/vabysmo-market-report-2026-roche-eye-drug-growth-forecast 2026-06-03T05:28:30.574Z monthly 0.5 https://novapharmanews.com/eu/news/glyconex-gnx1021-pmda-approval-phase-1-trial-gastrointestinal-cancers 2026-06-03T05:28:32.578Z monthly 0.5 https://novapharmanews.com/us/news/psoriasis-clinical-trial-pipeline-90-companies-2026 2026-06-03T13:58:38.371Z monthly 0.5 https://novapharmanews.com/us/news/meiragTx-aav-haqp1-gene-therapy-xerostomia-3-year-data-april-2026 2026-06-03T08:08:47.790Z monthly 0.5 https://novapharmanews.com/us/news/corbus-pharmaceuticals-crb-913-obesity-drug-canyon-1-trial-enrollment-complete 2026-06-03T11:52:28.311Z monthly 0.5 https://novapharmanews.com/us/news/actuate-therapeutics-elraglusib-pancreatic-cancer-survival-nature-medicine 2026-06-03T11:52:19.218Z monthly 0.5 https://novapharmanews.com/us/news/dupont-amberchrom-xt-sl-chromatography-resins-biopharmaceutical-manufacturing 2026-06-03T17:27:43.972Z monthly 0.5 https://novapharmanews.com/us/news/vasa-therapeutics-lilly-tunelab-ai-camkii-inhibitor-partnership 2026-06-03T11:52:45.128Z monthly 0.5 https://novapharmanews.com/us/news/synusight-biotech-sst001-alpha-synuclein-pet-tracer-nmpa-approval-phase-1-trial 2026-06-03T11:52:46.385Z monthly 0.5 https://novapharmanews.com/us/news/oryon-cell-therapies-appoints-burkhard-blank-chief-medical-officer 2026-06-03T11:52:45.972Z monthly 0.5 https://novapharmanews.com/us/news/amneal-launches-albuterol-beclomethasone-respiratory-inhalers-2026 2026-06-03T13:57:15.035Z monthly 0.5 https://novapharmanews.com/us/news/bright-path-fy2027-budget-domestic-pharmaceutical-manufacturing 2026-06-03T11:52:18.499Z monthly 0.5 https://novapharmanews.com/us/news/partner-therapeutics-bizengri-fda-application-cholangiocarcinoma-nrg1-fusion 2026-06-03T11:52:42.351Z monthly 0.5 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-alcohol-use-disorder-trial-results 2026-06-03T05:29:01.024Z monthly 0.5 https://novapharmanews.com/us/news/praxis-precision-medicines-fda-accepts-ulixacaltamide-hcl-essential-tremor-nda 2026-06-03T17:34:33.747Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-filspari-sparsentan-fsgs-first-treatment-rare-kidney-disease 2026-06-03T14:34:07.484Z monthly 0.5 https://novapharmanews.com/us/news/apotex-fda-approval-generic-infuvite-adult-injection-exclusivity 2026-06-03T11:52:47.125Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-orphan-drug-rarecure-ert-2026 2026-06-03T05:29:04.630Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-migraease-new-migraine-drug-2024 2026-06-03T09:55:55.472Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-expanded-indication-elahere-2024 2026-06-03T16:17:09.761Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cardioshield-hfpef-2026 2026-06-03T16:07:30.625Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-vitacorp-antibiotic-priority-review-2024 2026-06-03T05:29:12.617Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-neurovance-xr-pediatric-adhd-2026 2026-06-03T05:29:14.636Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-lumagen-gene-therapy-2024 2026-06-03T14:14:13.786Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-biosimilar-insulin-lispro-biosolve-2026 2026-06-03T11:52:42.153Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-oncocure-trk-inhibitor-2024 2026-06-03T05:29:20.622Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cart-t20-car-t-therapy-mantle-cell-lymphoma-2026 2026-06-03T11:52:27.645Z monthly 0.5 https://novapharmanews.com/eu/news/ema-implement-ai-system-drug-safety-2024 2026-06-03T05:29:24.630Z monthly 0.5 https://novapharmanews.com/eu/news/european-commission-launches-blockchain-pilot-pharmaceutical-supply-chain-2024 2026-06-03T05:29:26.651Z monthly 0.5 https://novapharmanews.com/apac/news/nmepa-priority-review-ai-diagnostic-early-cancer-2024 2026-06-03T11:52:23.701Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-approval-ai-platform-personalized-medicine-oncology-2024 2026-06-03T11:52:23.708Z monthly 0.5 https://novapharmanews.com/us/news/fda-launches-blockchain-pilot-program-pharmaceutical-supply-chain-2024 2026-06-03T11:52:43.812Z monthly 0.5 https://novapharmanews.com/us/news/fda-implement-ai-powered-expedited-drug-review-2027 2026-06-03T12:11:26.526Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-renoprotect-diabetic-kidney-disease-therapy-2024 2026-06-03T05:29:36.643Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-airflow-inhalable-severe-asthma-2026 2026-06-03T05:29:38.666Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-osteobuild-bone-building-agent-severe-osteoporosis-2026 2026-06-03T05:29:40.657Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-arterioflow-peripheral-artery-disease-2026 2026-06-03T09:32:52.795Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-cholesterolrx-high-cholesterol-2024 2026-06-03T05:29:48.823Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opti-sight-glaucoma-2026 2026-06-03T11:52:36.855Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-microbalance-crohns-disease-2026 2026-06-03T11:52:42.356Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-somnirestore-chronic-insomnia-2026 2026-06-03T16:30:27.757Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-neurobloc-non-opioid-pain-reliever-2026 2026-06-03T05:29:52.662Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lysoclear-lysosomal-storage-disorders-2026 2026-06-03T05:29:54.665Z monthly 0.5 https://novapharmanews.com/eu/news/ema-conditional-approval-car-t-relapsed-b-cell-lymphoma-2024 2026-06-03T11:52:33.767Z monthly 0.5 https://novapharmanews.com/us/news/fda-breakthrough-therapy-targtex-tx202-glioblastoma-2024 2026-06-03T11:52:44.210Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bria-cell-bria-imt-car-t-therapy-advanced-breast-cancer-2024 2026-06-03T15:35:16.187Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-zepzelca-lurbinectedin-cancer-treatment 2026-06-03T12:43:51.019Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-amgen-tarlatamab-imdylltra-small-cell-lung-cancer 2026-06-03T13:09:42.511Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-adstiladrin-gene-therapy-bladder-cancer 2026-06-03T05:30:06.677Z monthly 0.5 https://novapharmanews.com/eu/news/ema-recommends-imdylltra-tarlatamab-small-cell-lung-cancer-approval 2026-06-03T16:58:12.671Z monthly 0.5 https://novapharmanews.com/eu/news/ema-virtual-control-groups-reduce-animal-testing-drug-development 2026-06-03T07:51:53.145Z monthly 0.5 https://novapharmanews.com/us/news/fda-manufacturing-precheck-pilot-program-streamline-oversight 2026-06-03T11:52:43.803Z monthly 0.5 https://novapharmanews.com/us/news/real-world-evidence-transforms-drug-development-fda-regulatory-framework 2026-06-03T11:52:43.439Z monthly 0.5 https://novapharmanews.com/us/news/fda-untitled-letters-pharmaceutical-marketing-violations-database 2026-06-03T06:06:13.593Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-higher-dose-wegovy-7-2mg-weight-loss-priority-review 2026-06-03T05:30:18.683Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-avlayah-hunter-syndrome-neurologic-treatment 2026-06-03T11:52:28.071Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-kresladi-first-gene-therapy-lad-i-leukocyte-adhesion-deficiency 2026-06-03T05:30:22.700Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-foundayo-orforglipron-priority-voucher-program 2026-06-03T12:15:37.410Z monthly 0.5 https://novapharmanews.com/eu/news/ema-analysis-ai-pharma-rd-investment-2024 2026-06-03T11:52:32.158Z monthly 0.5 https://novapharmanews.com/eu/news/ema-accelerated-assessment-novel-mrna-vaccine-platforms-2024 2026-06-03T11:52:32.225Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approval-gene-therapies-neurological-disorders-2024 2026-06-03T11:52:29.812Z monthly 0.5 https://novapharmanews.com/eu/news/ema-clinical-trials-regulation-rare-disease-2026 2026-06-03T11:52:29.735Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-dermtech-skinguard-severe-eczema-2026 2026-06-03T08:26:08.949Z monthly 0.5 https://novapharmanews.com/eu/news/ema-blockchain-pharmaceutical-supply-chain-2024 2026-06-03T05:30:45.200Z monthly 0.5 https://novapharmanews.com/eu/news/ema-gdpr-impact-pharmaceutical-data-2024 2026-06-03T11:13:05.018Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-data-integrity-requirements-guide-2024 2026-06-03T11:52:23.710Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cognimax-alzheimers-2026 2026-06-03T11:52:43.033Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-vitarestrore-age-related-macular-degeneration-2026 2026-06-03T05:30:44.711Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-nasoclear-pediatric-rsv-2026 2026-06-03T05:30:46.725Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-revitalize-chronic-fatigue-syndrome-2026 2026-06-03T07:42:06.245Z monthly 0.5 https://novapharmanews.com/eu/news/ema-ai-powered-clinical-trial-matching-patient-recruitment-2024 2026-06-03T05:30:50.725Z monthly 0.5 https://novapharmanews.com/eu/news/ema-regulatory-outlook-digital-therapeutics-europe-2024 2026-06-03T17:07:05.569Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-ai-clinical-trial-matching-china-2024 2026-06-03T11:52:23.711Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-telemedicine-apac-opportunities-challenges-2024 2026-06-03T11:52:42.507Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-genecorrect-gene-therapy-cystic-fibrosis-2026 2026-06-03T16:08:43.996Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-myorepair-breakthrough-therapy-2026 2026-06-03T11:52:37.225Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-oncoblock-refractory-aml-2024 2026-06-03T11:52:36.604Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-xylocor-nda-advanced-melanoma-2024 2026-06-03T15:22:19.890Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-repatha-evolocumab-cardiovascular-prevention-2024 2026-06-03T11:52:45.120Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-tecentriq-atezolizumab-es-sclc-2024 2026-06-03T12:37:17.555Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-advanced-rcc-2024 2026-06-03T05:31:10.850Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-keytruda-adjuvant-stage-iii-melanoma-2024 2026-06-03T16:15:35.238Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-aduhelm-alzheimers-2021 2026-06-03T15:53:05.929Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-dupixent-eosinophilic-esophagitis-2024 2026-06-03T05:31:16.874Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-johnson-johnson-stelara-ulcerative-colitis-2024 2026-06-03T11:52:42.467Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-imfinzi-durvalumab-stage-iii-nsclc-2024 2026-06-03T11:19:12.382Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-trikafta-cystic-fibrosis-children-2024 2026-06-03T11:10:25.615Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mounjaro-weight-management-2024 2026-06-03T17:14:56.590Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cosentyx-hidradenitis-suppurativa-2024 2026-06-03T15:59:37.947Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-moderna-mrna-1345-rsv-vaccine-2024 2026-06-03T11:34:04.018Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-zithromax-pediatric-cap-2026 2026-06-03T05:31:30.882Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-revivcor-etanercept-biosimilar-heart-failure-2024 2026-06-03T11:52:42.166Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-breakthrough-innovent-kras-g12c-inhibitor-2024 2026-06-03T11:52:22.795Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-accepts-shionogi-influenza-drug-sakigake-2024 2026-06-03T11:52:22.881Z monthly 0.5 https://novapharmanews.com/apac/news/cdsco-policy-changes-generics-market-growth-india-2024 2026-06-03T05:31:38.894Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-sakigake-designation-regenerative-medicine-market-access-2024 2026-06-03T11:52:06.123Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-priority-review-pathway-innovative-drug-approvals-2024 2026-06-03T15:30:25.521Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lumasiran-acute-hepatic-porphyria-2026 2026-06-03T05:31:44.883Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-inhalex-copd-2026 2026-06-03T05:31:46.885Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-rapiclot-tranexamic-acid-trauma-2026 2026-06-03T15:26:53.644Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-tarzenta-advanced-her2-negative-breast-cancer-2024 2026-06-03T11:52:36.603Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-ritempro-parkinsons-2026 2026-06-03T05:31:59.196Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-expedited-review-novel-melanoma-therapies-2024 2026-06-03T05:31:54.892Z monthly 0.5 https://novapharmanews.com/apac/news/tga-innovation-report-australian-biotech-solid-tumor-car-t-2024 2026-06-03T05:31:56.899Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-tevimbra-tislelizumab-escc-2024 2026-06-03T14:20:58.896Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-wainua-eplontersen-hattr-pn-2024 2026-06-03T16:34:05.115Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-sanofi-altuviiio-hemophilia-a-2024 2026-06-03T10:27:02.899Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-augtyro-repotrectinib-ros1-nsclc-2024 2026-06-03T17:58:48.514Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-litfulo-ritlecitinib-alopecia-2024 2026-06-03T16:51:07.141Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-gmp-standards-foreign-manufacturers-impact-2024 2026-06-03T17:40:26.912Z monthly 0.5 https://novapharmanews.com/eu/news/mhra-vs-ema-regulatory-pathway-strategy-2024 2026-06-03T05:32:10.912Z monthly 0.5 https://novapharmanews.com/eu/news/ema-market-analysis-orphan-drug-pricing-reimbursement-2024 2026-06-03T17:08:29.067Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-accelerated-approval-orphan-drugs-impact-future-trends-2024 2026-06-03T18:02:16.832Z monthly 0.5 https://novapharmanews.com/apac/news/ich-guidelines-biosimilar-development-apac-2024 2026-06-03T11:57:31.013Z monthly 0.5 https://novapharmanews.com/apac/news/cdsco-forecasting-biosimilar-market-growth-india-2024 2026-06-03T11:57:06.587Z monthly 0.5 https://novapharmanews.com/apac/news/tga-pmda-uptake-adalimumab-biosimilars-2024 2026-06-03T11:57:30.240Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-biosimilar-framework-trastuzumab-adoption-2024 2026-06-03T11:57:21.457Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-biosimilar-approval-pathway-analysis-2024 2026-06-03T15:53:25.336Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-repatha-pediatric-hefh-2024 2026-06-03T05:32:26.941Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-adzynma-thrombotic-thrombocytopenic-purpura-2024 2026-06-03T05:32:28.945Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-otc-naloxone-nasal-spray-opioid-overdose-2024 2026-06-03T09:32:29.452Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-sotorasib-kras-g12c-nsclc-2024 2026-06-03T05:32:32.934Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-veozah-fezolinetant-menopause-2024 2026-06-03T13:44:04.688Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-pmda-tga-pompe-disease-market-analysis-2024 2026-06-03T11:52:23.570Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-omidubicel-onlv-2026 2026-06-03T16:23:36.353Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-updated-covid19-vaccines-fall-2024 2026-06-03T05:32:40.937Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bosulif-pediatric-cml-2024 2026-06-03T05:32:42.956Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-ztalmy-ganaxolone-cdkl5-deficiency-2024 2026-06-03T15:14:50.434Z monthly 0.5 https://novapharmanews.com/eu/news/ema-impact-eu-pharmaceutical-strategy-api-manufacturing-2024 2026-06-03T11:52:19.071Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-gastric-cancer-2024 2026-06-03T15:21:47.498Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-breyanzi-car-t-mantle-cell-lymphoma-2024 2026-06-03T05:32:50.949Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-mirvetuximab-soravtansine-elahere-2026 2026-06-03T16:26:07.617Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-elarek-osteoporosis-prevention-2026 2026-06-03T05:32:55.027Z monthly 0.5 https://novapharmanews.com/eu/news/ema-legislation-reform-market-access-innovation-2024 2026-06-03T14:57:00.972Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-approval-bevacizumab-biosimilar-china-2024 2026-06-03T17:34:09.221Z monthly 0.5 https://novapharmanews.com/eu/news/ema-marketing-authorization-denosumab-biosimilar-2024 2026-06-03T12:58:24.687Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-interchangeable-biosimilar-ustekinumab-2024 2026-06-03T16:57:41.865Z monthly 0.5 https://novapharmanews.com/eu/news/chmp-positive-opinion-car-t-therapy-relapsed-b-cell-lymphoma-2024 2026-06-03T11:52:33.792Z monthly 0.5 https://novapharmanews.com/eu/news/ema-legislation-reform-biopharma-innovation-2024 2026-06-03T11:52:33.837Z monthly 0.5 https://novapharmanews.com/apac/news/tga-australia-early-phase-trials-analysis-2024 2026-06-03T05:33:08.967Z monthly 0.5 https://novapharmanews.com/eu/news/ema-artificial-intelligence-clinical-trials-guidelines-2024 2026-06-03T15:20:42.149Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-anti-inflammatory-atopic-dermatitis-2024 2026-06-03T10:25:34.434Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-amgen-bispecific-antibody-colorectal-cancer-2024 2026-06-03T11:52:18.737Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-syfovre-geographic-atrophy-2023 2026-06-03T17:12:36.353Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-endeavorrx-digital-therapeutic-adhd-2024 2026-06-03T07:43:54.940Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-roche-ntrk-fusion-therapy-2024 2026-06-03T18:06:39.582Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-casgevy-gene-therapy-sickle-cell-2023 2026-06-03T18:11:44.159Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-humira-biosimilar-interchangeable-2023 2026-06-03T17:55:10.182Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-gilead-hiv-bimonthly-treatment-2024 2026-06-03T05:33:27.009Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-astrazeneca-wilson-disease-2024 2026-06-03T05:33:28.995Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-donanemab-alzheimers-2024 2026-06-03T05:33:30.997Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-novartis-breast-cancer-treatment-2024 2026-06-03T15:25:29.803Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lumakras-nsclc-2023 2026-06-03T13:46:32.162Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-talquetamab-multiple-myeloma-2024 2026-06-03T16:04:05.198Z monthly 0.5